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The diatoms make up the largest and most important group of marine microalgae. They are 
responsible for a quarter of all inorganic carbon fixation in the ocean and are thus of immense 
importance for global CO2 sequestration. This makes them good candidates for biological 
carbon capture and utilization (CCU) by mass cultivation using CO2 emissions from industrial 
point sources. Large scale cultivation of marine diatoms will produce valuable biomass 
containing marine lipids and proteins with possible commercial application. Commercial 
production of biomass requires extensive knowledge on the species to be cultivated in terms of 
optimal cultivation conditions, but also on the bioactivity, cytotoxicity and how the species 
responds to changing cultivation conditions.  
Most studies on the bioactivity and biochemistry of marine diatoms have been performed on 
species cultivated in the laboratory. Cultivation conditions are known to affect the biochemistry 
of diatoms, and large-scale cultivation will inevitably lead to a change in the environmental 
conditions. The present study was therefore designed to investigate how P. glacialis cultivated 
in large scale responds to changes in abiotic and biotic cultivation conditions.  
The first study was designed to investigate whether the direct addition of factory smoke as a 
source of CO2 would trigger production of bioactive or cytotoxic compounds in P. glacialis. 
Bioactivity testing revealed activity in anticancer, antibacterial and antibiofilm assays, in 
addition to cytotoxicity against human lung fibroblasts and effect on the development of sea 
urchin larvae. Nonetheless, the addition of factory smoke did not increase the cytotoxicity of 
P. glacialis, nor did it change the beneficial antibacterial and antibiofilm activity. These results 
are favourable for further development of large-scale production of diatom biomass.  
P. glacialis was co-cultivated with zooplankton to investigate whether the bioactivity and 
metabolic expression of the diatom would change when exposed to grazing pressure. The 
bioactivity testing revealed that the presence of zooplankton increased the cytotoxicity of P. 
glacialis towards human normal lung fibroblasts. Investigation of active compounds and 
metabolomic analysis showed that the grazing pressure possibly influence the carotenoid 
concentration in P. glacialis. It was also found that the bioactivity might be traced to primary 
metabolites such as chlorophyll derived compounds. The study also showed that the use of 
OSMAC (one strain many compounds) could be a useful method for further investigation of 
the bioactivity of diatoms.  
Investigation of the antibiofilm activity of P. glacialis resulted in isolation of two compounds 
showing inhibition of biofilm formation by Staphylococcus epidermidis. The compounds 
isolated were methyl 3-hydroxyoctadecanoate and a pheophorbide-like compound. This is the 
first time compounds with antibiofilm activity have been isolated from P. glacialis as well as 





Kiselalgene utgjør den største og viktigste gruppen av marine mikroalger. De er ansvarlige for 
en fjerdedel av all uorganisk karbonfiksering i havet og er dermed av enorm betydning for det 
globale CO2 opptaket. Dette gjør dem til gode kandidater for biologisk karbonfangst og -
utnyttelse (CCU) i massedyrking ved bruk av CO2 fra industrielle punktutslipp. Storskala 
dyrking av marine kiselalger vil produsere verdifull biomasse som inneholder marine lipider 
og proteiner med mulig kommersiell anvendelse. Kommersiell produksjon av biomasse krever 
stor kunnskap om arten som skal dyrkes med tanke på best mulige dyrkingsforhold, men også 
om bioaktivitet, toksisitet og hvordan arten reagerer på endrede dyrkingsforhold. 
De fleste studier på bioaktivitet og biokjemi av marine kiselalger er utført på arter dyrket i 
laboratoriet. Det er kjent at dyrkingsforhold påvirker biokjemien til kiselalger, og dyrking i stor 
skala vil uunngåelig føre til en endring i miljøforholdene. Denne studien ble derfor designet for 
å undersøke hvordan Porosira glacialis dyrket i stor skala reagerer på endringer i abiotiske og 
biotiske dyrkingsforhold. 
Den første studien undersøkte om direkte tilsetning av fabrikkrøyk som kilde til CO2 ville endre 
produksjon av bioaktive eller toksiske forbindelser i P. glacialis. Bioaktivitetstesting avdekket 
aktivitet i alle tester: anticancer, antibakteriell og anti-biofilm. I tillegg viste resultatene 
toksisitet som hemmet utvikling av kråkebolle-larver og humane lungefibroblaster. Likevel 
økte ikke tilsetting av fabrikkrøyk toksisiteten til P. glacialis, og den hemmet heller ikke den 
gunstige antibakterielle og anti-biofilm-aktiviteten til algene. Disse resultatene er svært positive 
for videre utvikling av storskala produksjon av kiselalger. 
P. glacialis ble dyrket sammen med dyreplankton for å undersøke om bioaktiviteten og utrykket 
av metabolitter ville endre seg når de ble utsatt for stress i form av beitetrykk. Testing av 
bioaktivitet avslørte at tilstedeværelsen av zooplankton økte toksisiteten til P. glacialis mot 
humane normale lungefibroblaster. Undersøkelse av aktive forbindelser og metabolittprofiler 
viste at beitetrykket muligens påvirker konsentrasjonen av karotenoider i P. glacialis, og at 
bioaktiviteten muligens kan spores til primære metabolitter som klorofyllderivater. Studien 
viste også at bruk av OSMAC (one strain many compounds) kunne være en nyttig metode for 
videre undersøkelse av bioaktiviteten til kiselalger. 
Undersøkelse av anti-biofilm-aktiviteten til P. glacialis resulterte i isolasjon av to forbindelser 
som viser inhibering av biofilmdannelse av bakterien Staphylococcus epidermidis. De isolerte 
forbindelsene var metyl-3-hydroksyoktadekanoat og en pheophorbid-lignende struktur. Dette 
er første gang en forbindelse med anti-biofilm-aktivitet er blitt isolert fra P. glacialis, og det 
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 1 
1 Introduction  
1.1 The microalgae group: diatoms 
The diatoms impact our daily life to a higher degree than what most people recognize. Even if 
they only make up about 0.5% of Earth’s photoautotrophic biomass, they are responsible for 
approximately 40% of the annual global primary production of organic carbon, which 
demonstrates their extreme growth rates compared to their terrestrial photosynthetic 
counterparts. Also, this translates to a higher CO2 capture than all terrestrial rainforests 
combined [1-4]. Each year diatoms fixate a quarter of all inorganic carbon in the ocean and are 
therefore of immense importance for global CO2 sequestration [5]. These microscopic 
photosynthetic organisms are in many ways the Oceans invisible forest and play an important 
role in regulating our climate [6].  
The diatoms are a highly diverse group and can be found in any thinkable habitat on Earth [7]. 
They belong to the heterokontophytes, commonly referred to as brown algae due to their 
golden-brown coloured chloroplasts. About 12 000 species are described today, and a higher 
number is estimated to exist [8]. This number is debated, and ranges from 20,000 to 200,000  
Figure 1: Illustration of diatom frustule shapes, by Ernst Haeckel in his book Kunstformen der Natur published in 1899. The 
cell to the left is a pennate diatom with bilateral symmetry. The cell to the right is a centric diatom with radial symmetry. 
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species [8, 9]. Nevertheless, the diatoms are regarded as the most successful group of 
microalgae with respect to diversity as well as biomass and primary production. The immense 
species diversity can be reflected in the extravagant morphological variety among the different 
genera of diatoms. The diatoms are divided into two groups based on the shape of their cell 
wall, called the frustule: centric diatoms or pennate diatoms, seen in Figure 1 [10]. The structure 
of the diatom frustule can be compared to a Petri dish, where the top half (epitheca) overlaps 
the bottom half (hypotheca). The frustule is composed by amorphous silica, giving them a glass 
cell wall [11]. Everyone who has observed diatoms in a microscope have seen the intricate 
structures of the frustule which is the true hallmark of the diatoms. The species we know today 
are mainly identified by the structure of their frustule, formation of chains or arrangement of 
setae (thin brush like structures protruding the frustule). Illustrations made by Ernst Haeckel at 
the end of the 19th century (Figure 2) show that diatoms have been studied for centuries, and  
displays the great morphological 
variation [10]. The Thalassiosira 
pseudonana genome (32.4 
megabases) was the first diatom to 
be fully sequenced [12], and a 
genome sequencing of 
Phaeodactylum tricornutum (27.4 
megabases) followed not too long 
after [13]. A comparison between 
the two showed that only 57% of the 
genes are shared, which can be 
compared to the same portion of 
genes shared between humans and 
fish. Revealing a great genetic 
diversity among these microalgae. 
Diatoms divide through binary 
fission. The two valves of the 
frustule divide, and both become the 
epitheca of the new cells, while a 
new hypotheca is formed to fit 
inside the epitheca. Thus, with each 
Figure 2: Illustration of a range of diatoms species by Ernst Haeckel in the 
book Kunstformen der Natur published in 1899. 
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mitotic division, the daughter-cells decrease in size, known as the MacDonald-Pfitzer 
hypothesis [14]. This decrease in cell size cannot continue eternally and a sexual reproduction 
with restoration of cell size therefore takes place periodically. This process can also happen 
during nutrient depletion, or as a response to unfavourable light conditions [14-16].  
The diatoms are not only beautiful to observe in the microscope, but they also have a lot to offer 
on the inside. The diatoms are the dominant primary producers in the temperate and Arctic 
oceans, and they dominate all areas where fish production is high e.g., the Benguela, Humboldt 
and Canary upwellings as well as the Barents sea [17]. Being at the base of the marine food 
chain, they lay the foundation for all marine life (Figure 3). Diatoms and other phytoplankton 
are regarded as the main food source for zooplankton, early life stages of crustaceans, bivalves 
and fish larvae [18]. The valuable nutrients from the marine diatoms are transferred upwards in 
the food chain via zooplankton to fish and marine mammals, often ending up at our dinner table. 
Diatoms supply us with important fatty acids required in our diet. The marine long-chained 
polyunsaturated fatty acids (LC-PUFAs) eicosapentaenoic acid (EPA, C20:5, n-3) and 
docosahexaenoic acid (DHA, C22:6, n-3) which are supplied through consumption of high-fat 
fish are originally synthesized by phytoplankton [19-21]. EPA and DHA are linked to reduction 
of cardiovascular disease, proper brain development and function and prevention of certain 
types of cancer [22]. EPA and DHA are synthesized from the two precursors alpha-linolenic 
Figure 3: Marine food web of the Northern Norwegian coast. Figure: R. Osvik 
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acid (ALA, C18:3, n-3) and linoleic fatty acid (LA, C18:2, n6) which are the essential fatty 
acids. Humans and other mammals can convert ALA and LA to EPA and DHA, but the 
conversion rate is low [23]. Thus, the diatoms are essential for the survival of fish larvae, marine 
zooplankton [24, 25] and eventually, us [22, 26].   
1.2 The spring bloom  
The abundance and species composition of phytoplankton varies seasonally, and few species 
are present year-round [17]. Light is naturally the main limiting factor which hinders high 
phytoplankton production during the winter. Photoautotrophic organisms harvest visible light 
(400-700 nm) using photosynthetic pigments to produce organic bound carbon from CO2 [27, 
28]. The sun resides below the horizon during winter above the Arctic Circle, leaving little light 
for primary production. The March vernal equinox marks the beginning of spring in the 
Figure 4: Satellite picture illustrating the immense prevalence of a microalgae bloom along 




Northern Hemisphere. As the sun rises higher on the horizon and the daily photoperiod 
increases, the annual spring bloom commence. Upwelling from the ocean floor carries nutrients 
and phytoplankton spores up to the euphotic zone. The spores germinate into vegetative cells 
that divide further while species appear in successions [28, 29]. As mentioned, diatoms 
dominate the spring bloom in both the temperate and polar seas. During this bloom the diatom 
biomass grow exponentially, reaching cell numbers of 6-10 x 106 cells L-1 at its peak [17]. The 
spring bloom is such a massive event that its prevalence can be seen from space (Figure 4).  
Equation 1:  
6𝐶𝑂! + 6𝐻!𝑂 + ℏ𝑣 = 	𝐶"𝐻#!𝑂" +	𝑂! + ℎ𝑒𝑎𝑡 
 
The photosynthetic equation (Equation 1) illustrates that carbohydrates are produced from 
inorganic carbon and water, using light as the energy source. By taking up nitrogen, phosphorus 
and other inorganic nutrient elements from the surrounding water, these primary producers are 
able to synthesize other nutritious compounds like proteins and lipids. Carbon and hydrogen 
are nearly always present in surplus in the ocean, while inorganic bound nitrogen, phosphorus 
and iron are often limiting in oligotrophic areas and at the end of bloom events [30]. Silicate is 
also essential for the growth of diatoms, and the access will gradually decline during the bloom.  
Some diatoms secret polysaccharides functioning as a gel to keep cells of the same species 
together in close contact. This gel and the diatoms photorespiration release dissolved organic 
carbon (DOC), which is an important substrate for marine bacteria, thus diatoms do not only 
produce nutrients for higher trophic levels, but also for those below [30-32]. The nutrient 
limitation combined with grazing pressure leads to the end of the spring bloom. Parts of the 
remaining diatom cells will dissolve and become substrate for marine bacteria. What is left over 
will eventually sink to the bottom sediments where they form resting spores and await the right 
conditions for the next bloom to commence [28, 33, 34].  
1.3 Planktonic interactions in the ocean – a network of chemical 
signals 
The open ocean incorporates webs of interactions not visible to the naked eye. Microalgae, 
bacteria and zooplankton are termed “plankton” since they are the drifters of the ocean. They 
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lack strong means of movement or swimming and are at the mercy of the oceanic currents and 
waves. In this moving habitat, they are in constant contact with each other, for better or worse. 
Their relationship can be of a symbiotic, commensal or parasitic nature, or a predator-prey 
relationship [35].  
1.3.1 Interactions between diatoms and bacteria 
The first radial centric diatoms appeared in the Jurassic [14], thus their morphology and genome 
have evolved and diversified over approximately 200 million years. And at the same time, their 
relationship with bacteria has been shaped over an evolutionary timescale. The co-evolution 
can be reflected in the diatom genomes. Genome sequencing of P. tricornutum and T. 
pseudonana revealed a remarkably high number of genes transferred from bacteria to the 
diatoms [12, 13]. This shows that horizontal gene transfer from bacteria has been one of the 
main driving forces during the evolution of diatoms. Studying these planktonic relationships in 
situ is quite challenging as the oceans are in constant movement. Their terrestrial counterpart, 
the relationship between plants and microorganisms has been thoroughly studied. One example 
is the symbiotic relationship between plants and bacteria, where N2 fixating bacteria live in the 
plants root nodule system, providing the essential N2 for the plants [36]. These symbioses are 
easier to observe as they are confined to a limited area, and to a large extent, non-motile. Studies 
of diatom-bacteria interactions have mostly taken place in the laboratory, in the littoral zone, 
or on benthic diatoms [31]. Nonetheless, surveys of the plankton communities in vivo, like the 
Tara Ocean, have found that, similar to terrestrial plants, there are symbioses between diatom 
and N2-fixating cyanobacteria in the marine environment as well, especially in low-nutrient 
areas [37, 38].  
Interactions between diatoms and bacteria take place for the most part in the phycosphere of 
the diatoms. The term “phycosphere” was first published in 1972, and is defined as the region 
extending outward from the algal cell and is the aquatic analogue to the rhizosphere found in 
terrestrial plant roots [31, 39]. Several studies on the phycosphere have been conducted, with 
the aim of exploring the bacterial diversity that the diatoms are surrounded with. In a study by 
Sapp et al. [40] the bacterial community of the phycosphere of four different diatom species, 
Thalassiosira rotula, Skeletonema costatum, Pseudonitzschia pungens and Guinarida 
delicatula, were sequenced. The study revealed that Alphaproteobacteria and 
Gammaproteobacteria were the predominant bacterial groups associated with these diatoms and 
accounted for 43% and 37% respectively.  
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When cultivating diatoms, either in the laboratory or in an industrial scale, the cultures are 
rarely axenic. Bacteria will always be present, but usually they don’t cause any problems for 
the diatoms. Cultivation of photoautotrophic diatoms does not require addition of organic 
nutrients, and the traditional diatom cultivation medium, Guillard F/2 [41], does not contain an 
organic carbon source. Yet, bacteria thrive in many diatom cultures. Most diatom species 
excrete an extracellular matrix mostly made up of carbohydrates. This matrix can often be seen 
in a diatom monoculture cultivated in the lab, as it tends to form a viscous gel surrounding the 
cells. The biomolecules form a perfect base of DOC for bacteria in the diatoms phycosphere 
[40, 42]. Just like multicellular eukaryotes house microbial communities (e.g. gut microbes), 
several studies have shown that diatoms secrete specific metabolites into their phycosphere to 
promote attachment of beneficial bacteria (e.g. rosmarinic acid) or supress the attachment of 
opportunistic ones (e.g. azelaic acid) [43]. Beneficial bacteria can be strains which diatoms rely 
on for synthesis of vitamin B12 (Cobalamin) [44, 45]. Thus, they can coexist and benefit from 
each other.  
There are examples of far less beneficial relationships. Some algicidal bacteria can enter the 
phycosphere and release compounds capable of killing the diatom [31]. Kordia algicida is 
known to produce a protease with algicidal activity against species of Skeletonema, 
Thalassiosira and Phaeodactylum [46]. Diatoms also have defences against harmful bacteria. 
Antibacterial activity in diatoms has been linked to polyunsaturated fatty acids and has been 
found in several diatom species: S. costatum, P. tricornutum and Navicula delognei [47-49].  
1.3.2 Interactions between diatoms and zooplankton  
Marine herbivores, such as copepods, have been known to time their reproduction so that larvae 
development match with the peak of the spring bloom. This concept is part of what is termed 
the Cushing´s match-mismatch hypothesis [50].  By such timing the zooplankton stock can take 
advantage of the abundance of nutrients provided by the blooming primary producers. A 
mismatch on the other hand is bad timing that leads to transfer of less nutritious material up the 
food chain, affecting the next generation negatively [51]. Diatoms have traditionally been 
regarded as a significant food source for herbivores, and the nutritional value of the diatoms is 
highly important for the transfer of energy upwards in the food chain, supporting important 
fisheries [52-54]. Although, this predator-prey relationship was questioned in the beginning of 
the 1990s when several studies showed that certain diatom diets could have a negative effect 
on grazing copepods.  
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Ianora et al. reported in 1993 that a diet of Thalassiosira rotula seriously affected the hatching 
success of the eggs of the copepod Temora stylifera negatively [55]. Following this discovery, 
a series of studies uncovered the potential negative effect of a diatom diet on several copepod 
species [25, 56-58]. Diatoms showed a teratogenic effect meaning that the diet does not affect 
the grazer itself but rather the next generation [59]. Examples of familiar plant compounds with 
teratogenic effect are nicotine and alcohol, which both affect the foetal development in humans. 
In the case of copepods the teratogenic effect appears as production of abnormal eggs, 
interference with hatching of eggs or as malformation of nauplii larvae post hatching [54, 60]. 
The effect was shown to be dependent on density, as successful hatching of eggs increased with 
decreasing concentration of diatoms in the diet [61-63]. Oxylipins, especially polyunsaturated 
aldehydes (PUA) have been pinned as the main culprits of these harmful effects. Three low-
molecular PUAs were isolated from T. rotula, Skeletonema costatum and Pseudonitzschia 
delicatissima: 2-trans-4-cis-7-cis-decatrienal, 2-trans-4-trans-7-cis-decatrienal, 2-trans-4-
trans-decadienal which all had an effect on the embryonic development of Calanus 
helgolandicus [64]. Following this, a number of different PUAs have been isolated and both 
laboratory and field studies have confirmed the cytotoxic effect of diatoms [65, 66]. It was also 
discovered that a diatom diet did not only have a negative effect on copepods, but also other 
zooplankton species such as sea urchin larvae [67-71].  
PUAs are not produced and excreted by the diatoms to scare grazing copepods away from eating 
them. They are rather produced enzymatically within seconds after cell rupture due to feeding, 
by oxidation of polyunsaturated fatty acids (e.g. EPA and DHA) [72-74]. It has also been 
suggested that cell lysis towards the end of a diatom bloom causes release of PUA [75]. The 
release of PUAs to the environment could also affect the grazing pattern of planktonic 
herbivores [76]. The number of studies confirming PUAs cytotoxic effect on zooplankton could 
suggest that the diatoms are not as valuable a food source as one thought. Although not all 
diatoms are known to produce PUAs. In a study by Wichard et al. in 2005 [77], 50 species (71 
isolates) of diatoms were examined for production of PUA, and 27 were identified to contain 
PUAs, showing that it varies between species, and strains. Other studies have found no effect 
of PUAs on selected grazers [25, 78-81]. It has also been found that diatoms ability to produce 
PUAs can vary with season, and there are evidence that that stress due to nutrient deficiency 
can trigger PUA production [82, 83]. Although some species of diatoms have a negative effect 
on the hatching of copepods they are still a highly important nutrient source for the planktonic 
marine ecosystems (Figure 5).  
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Copepod species of Calanus sp. and Pseudocalanus sp. release chemical cues, taurine 
conjugated lipids, called copepodamides that affect the diatoms [84, 85]. These cues can be 
perceived by microalgae as a warning on the presence of grazers, and triggers both chemical 
and morphological changes in some diatom species. Chain-forming Skeletonema costatum 
reduce chain length in response to copepodamides [86, 87]. A reduction of chain length could 
sound counterintuitive as a defence mechanism. But the term “the bigger the better” does not 
apply here, as copepods have a lower grazing rate on singe cells [88]. Diatom Pseudo-nitzschia 
seriata responds by increasing production of domoic acid, the toxin known to cause amnesic 
shellfish poisoning, thus leading to harmful algae blooms [89]. These defence elicitors are the 
first to be identified in marine plankton and reveal how these small organisms can cause a 
cascade of chemical response in the planktonic food web. 
1.4 From primary producers in the ocean to industrial producers on 
land - Mass cultivation and carbon capture and utilization 
Similar to agricultural crops, marine algae can be cultivated and exploited for their valuable 
chemical contents. Microalgae have certain obvious advantages over traditional terrestrial 
crops: up to 20-fold higher productivity per area, does not compete with arable land, high 
growth rates (>100% increase in biomass per day), year-round production and high lipid content 
Figure 5: Oithona sp. feeding on the marine diatom P. glacialis. Intact cells can be seen in the stomach 
of Oithona sp. Photo: R. Osvik 
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[90]. The history of microalgae cultivation is a little over 100 years old. Chlorella vulgaris was 
the first green algae to be isolated and cultivated for the purpose of studying plant physiology 
[91]. Mass cultivation for production of biomass was first attempted in the late 1940s. Even 
though the industry has seen a growing interest in recent decades, less than 20,000 tons of 
microalgae biomass is produced globally each year (mainly phototrophic) [92]. This is a mere 
fraction of per million of the World’s soy production. Common microalgae products are 
carotenoids (e.g. astaxanthin, fucoxanthin and ß-carotene), lipids and polysaccharides [93]. 
Renewable production of biofuels from microalgae received great attention some decades ago 
[94-99], but the focus has shifted as the production was not economically viable [100]. Despite 
their vast species diversity, nutritional importance and high lipid content, diatoms have not been 
among the most sought-after microalgae for mass cultivation. They are underrepresented on the 
list of commonly cultivated species. Chlorella, Hematococcus, Rhodomonas and 
Nanochloropsis are widely exploited species, while Pheaocatylum tricornutum seems to be the 
only diatom that is cultivated at a larger scale for production of fatty acids [101]. Borowitzka 
and Vonshak define large-scale production to be >10 tons dry mass per annum which is enough 
for commercial high value products, such as pharmaceutical or nutraceutical products [100]. 
Other diatom genera such as Skeletonema, Thalassiosira and Chaetoceros are commercially 
exploited as live food in aquaculture [101]. 
Microalgal mass cultivation systems are found in a wide array of shapes and sizes. The design 
and variation are only limited by the imagination of the designer and the physical limitations of 
the structure. Despite the structural variations, the cultivation systems have one common 
important function: to facilitate optimal and economically sustainable algal biomass production 
by exposing the largest fraction of the microalgal cells to optimal production conditions. No 
optimal design exists today and there is no gold standard for photoautotrophic microalgae 
cultivation. Photobioreactors can be open or closed systems, both of which comes with their 
advantages and disadvantages [94]. Among the open reactors you find artificial ponds, tanks 
and raceways [91]. All these have relatively low production and maintenance cost and facilitate 
the use of direct sunlight. Nonetheless, the risk of uncontrollable environment and 
contamination by other species, both microalgal and bacterial, is high. Closed reactors are often 
formed as tubes or flat panels made of glass or plastic. Tubular photobioreactors have a high 
production cost, and are difficult to clean, though there is low risk of contamination. Ultimately, 
the choice of photobioreactor must be based on the requirements of the microalgae to be 
cultivated, and their preferred growth conditions [102].  
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The list of factors to consider before choosing a cultivation system is long: the biology of the 
producing species, energy input, water availability, nutrient, climate, light, temperature, the 
target product and environmental impact [91]. The last factor to be mentioned is the carbon 
source. All photoautotrophic organisms rely on CO2 as a carbon source. To achieve a viable 
production, addition of CO2 above the atmospheric concentration is essential. CO2 is one of the 
major costs of diatom cultivation, but can potentially be solved by industrial partnership [99].   
Emissions of CO2 has for many years been the culprit of the climate change we see today. 
Industry, fossil fuel, travel and so much of what we depend on in our daily lives emit large 
amounts of CO2. Various measures have been proposed to reduce the amount of CO2 emissions. 
In Norway alone greenhouse gas emissions were 50.3 million tons in 2019, 84 % of that being 
CO2 [103]. The Norwegian government has for several years worked towards a solution for 
carbon capture and storage (CCS), where CO2 emissions are captured and stored in a safe 
manner, often in geological reservoirs below the ground or beneath the seafloor [104]. Another 
way of handling CO2, which has received somewhat less attention, is carbon capture and 
utilization (CCU). This is a process where CO2 is regarded as a resource, rather than waste, 
which can be recycled and converted into more valuable products [105]. Captured CO2 can be 
utilized in chemical industry for production of methanol or urea for fertilization, it can be 
mineralized into solid carbon, the food industry can use it for carbonization of beer, or it can 
be used in production of various plastic materials. CCU can also be done by utilizing primary 
producers for CO2 sequestration. Diatoms can be of substantial help in such CO2 mitigation 
strategies. Emissions from point sources can be used as a carbon source in microalgae 
cultivation thus removing CO2 from the Earth’s atmosphere [102]. Mass cultivation of marine 
diatoms using CO2 directly from a point source is one method of CCU where one exploits the 
natural ability of photosynthetic organisms to capture CO2 and transforming it to valuable 
nutritious biomass. By connecting high-emission industries with diatom mass cultivation plants 
we can facilitate for a CCU symbiosis and the production of renewable marine biomass [106].  
1.5 Marine biodiscovery  
There is no doubt that the ocean has had an attraction on mankind since the beginning of time. 
The unknown, the inaccessibility and the vastness of the oceans has triggered the curiosity for 
new discoveries. Life began in the oceans, and out of our 36 known animal phyla, 34 are found 
in the ocean (15 being exclusively marine) while only 17 are found on land [107]. This great 
diversity has been an inspiration for scientists in the search for new bioactive compounds. 
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Although not nearly as widespread as terrestrial plant medicine, the use of marine species for 
medicinal purposes started long before we had access to new submersible technology. 
Chondrus crispus and Mastocarpus stellatus (red macroalgae) were used to cure symptoms of 
chest infections, while the red algae Porphyra umbilicalis as part of the diet were found to have 
an effect against cancer [108, 109]. After the development of technology for diving and 
submarines and ROVs for deep diving, we have been able to conduct a more methodical search 
for new and interesting chemistry among the marine biodiversity.  
More than half of the drugs on the market today are Natural Products (NPs), or synthetic and 
semi-synthetic compounds based on NPs [110]. Common for the NPs is that they originate from 
secondary metabolites. Primary metabolites are the essential for the producing organism for 
growth, development and reproduction. In contrast, secondary metabolites are not essential, but 
produced in given situations and conditions in order to enhance their chances in competitions 
with other. This could for example be toxin production to repel grazers and predators [111, 
112]. Almost all NPs in clinical use are from terrestrial sources, but of today there are 15 drugs 
from marine sources [109, 113]. Among these are 10 anticancer drugs, including Yondelis® 
from the tunicate Ecteinascidia turbinata against soft tissue sarcoma and ovarian cancer (2015) 
[114], Halaven® based on the pharmacophore from the sponge Halichondria okadai against 
breast cancer (2010) [115], Adcetris® from Dolabella auricularia against Hodgkin’s 
lymphoma and anaplastic large cell lymphoma (2011) [116], and Zepzelca™, isolated form a 
tunicate against metastatic small cell lung cancer [117]. The other drugs are Vira-A® with 
antiviral activity against Herpes Simplex virus [118] and Prialt®  from the cone snail Conus 
magus used as a pain killer for patients undergoing severe chronic pain [119]. In addition, three 
Omega-3 fatty acids from fish are used for treatment of hypertriglyceridemia: Lovaza®, 
Vascepa® and Epanova® [113]. 
As of 2020 [109, 113, 120], 23 marine NPs were in clinical trials phase I, II or III, and the 
search for new drugs is constantly ongoing among researchers in the field. One might question 
why there is a need for new drugs, and the reasons are plentiful. Living conditions have 
improved in many countries, increasing our life expectancy [121]. Living longer also means 
increase in cases of non-communicable diseases like cardiovascular diseases, cancers, asthma 
and diabetes, many of which there is no cure for today. Another reason for our increased life 
expectancy is the possibility to treat infectious bacterial diseases. Antibiotics have been used to 
treat serious infections since World War II. But already by the following decade, penicillin 
resistance had become a problem. Since then many new antibiotics have been discovered, but 
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resistance has developed towards nearly all of them [122]. Former lack of regulation, non-
prescription over the counter sale, extensive use in agriculture, and over use in general has 
increased the rate of resistance [122]. Simultaneously, antibiotic development has not been 
considered economically viable over the last years, and the recourses allocated to this purpose 
has decreased. All of this makes antibiotic resistance one of the greatest risks to human health 
in the future according to WHO. Apart from the non-treatable diseases we face today, new 
diseases can and will certainly also arise. It is inevitable not to mention the events of 2020, and 
the ongoing COVID-19 pandemic. The rapid global spread and occurrence of mutations of a 
new type of corona virus has showed us that there could be a sudden need for new treatments 
and new vaccines. Natural products have formerly contributed to treatments of MERS-CoV and 
influenza, and could be a source for drugs against viral diseases such as the one we are battling 
at this very moment [123].  
1.5.1 The role of diatoms in marine biodiscovery 
Today, there are no pharmaceuticals derived from diatoms (or microalgae in general), and they 
are perhaps less studied than invertebrates and bacteria. However, among the few species that 
are investigated, there is no lack of reported bioactivity [124-130]. The aforementioned 
polyunsaturated aldehydes (Figure 6) are not only teratogenic against zooplankton, but also 
have an anticancer activity against human lung adenocarcinoma and colon adenocarcinoma cell 
lines [128]. Miralto et al. [64] reported in 1999 that three aldehydes isolated from Skeletonema 
costatum, Pseudo-nitzschia delicatissima  and Thalassiosira rotula had an anticancer effect 
towards the colon cancer cell line Caco2. Monoacylglycerides (MAGs) isolated from 
Figure 6: Diatom derived polyunsatruated aldehydes (PUAs); (a) 2-trans-4-cis-7-cis-decatrienal; (b) 2-trans-4-trans-
7-cis-decatrienal; (c) 2-trans-4-trans-decadienal; (d) 2-trans-4-trans-octadienal; (e) 2-trans-4-trans heptadienal. 
Figure adapted from Martínez Andrade, 2018 [184]. 
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Skeletonema marinoi have displayed anticancer effects on colon cancer and haematological 
cancer [131]. The MAGs tested consisted of both EPA and DHA, w-3 PUFA with several 
documented beneficial health effects [124, 132, 133]. Diatoms produce a water-soluble 
polysaccharide called chrysolaminarin (Chrl) and can make up >50 % of the dry weight of the 
cell. Chrl have exhibited activity against two colon cancer cell lines (HT-29 and DLD1), but 
the commercial potential is yet to be developed [134, 135]. Anticancer effect has also been 
reported from the pigment fucoxanthin (Fx) produced by Odonotella aurita [136]. Fx is one of 
the carotenoids giving diatoms their golden-brown colour. It has also proven to be a quite 
interesting compound with an array of bioactivities, in addition to anticancer activity: 
antioxidant, anti-inflammatory, antihypertensive and antiobesity [137, 138]. A study by 
Lauritano et al. [139] investigated antiinflammatory activity in the benthic diatom 
Cylindrotecha closterium, and dereplication analysis showed that the activity was most likely 
caused by lysophosphatidylcholines and pheophorbide a, which are membrane compounds and 
chlorophyll a (Chl a) derivatives respectively. Apart from the bioactivity connected to specific 
diatom derived compounds, activity has also been reported from testing more complex chemical 
fractions. Fractions of extracts exhibiting anticancer, antiinflammatory, antibacterial and 
antibiofilm activity was found in studies screening several species of diatoms [125, 127, 129, 
130]. Some diatoms species of the genus Pseudo-nitizscha also produce a potent neurotoxin 
called domoic acid (DA). A toxin responsible for a specific type of shellfish poisoning termed 
amnesic shellfish poisoning due to one of the symptoms being memory loss [140]. The chemical 
structure of DA resembles that of glutamic acid, an important neurotransmitter in the 
mammalian nervous system. DA acts as a potential agonist of the glutamate receptors, and can 
therefore have potential in the study of neurodegenerative disease [140, 141]. All examples 
above proves that diatoms harbour a vast pharmaceutical potential, and though not realized yet, 
in time it could be turned in to valuable commercial products.  
Biodiscovery does not only cover the search for new drugs, but all compounds with a 
commercial interest. Thus, including nutraceuticals, “cosmeceuticals”, antifouling agents, 
enzymes or whatever bioactivity one might seek. Development of functional products is a lot 
faster than development of pharmaceuticals. Many companies opt for that route, as it offers 
lower risk and quicker potential return. Diatoms are packed with valuable nutrients: lipids (7.2-
23 %), proteins (12-59 %) and carbohydrates (4.6-9.8 %) [142-144]. Diatom derived w-3 PUFA 
for human consumption are already on the market. The Swedish company Simris Alg [145] has 
several products containing EPA from Phaeodactylum tricornutum sold worldwide. A valuable 
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marketing tool for algae derived w-3 PUFA is that it represents a “green” alternative, or the 
vegan alternative to products from cod liver, krill or Calanus species. With the increasing focus 
on sustainability, organic products and a reduction of meat intake this is a valuable point for 
producing diatom biomass for human consumption.  
Diatoms get their colour from a variety of carotenoids, among them β-carotene, fucoxanthin 
(Fx), and diadinoxanthin (Ddx). Fx from P. tricornutum is used in the dietary supplement 
FucoVitalä claimed to improve liver health due to antioxidative effect [146]. The antiobesity 
active Fx is used in a few weight-management products e.g. fücoTHINÒ  from Garden of Life 
[147]. The Fx in these products is derived from brown algae, but as diatoms has a higher 
content, and the access is not limited by seasonality in growth, diatoms can be a potential future 
source [135]. Due to the bioactivity of Fx, it can also be a promising candidate in the 
development of a new marine drug [136]. Apart from use in pharma- or nutraceuticals, 
carotenoids have potential as food supplements, food colorants or for cosmetic purposes [109].  
Fossilized diatom shells form “diatomaceous earth” which has a variety of applications, ranging 
from filter medium in water filtration systems, abrasive agent in tooth paste, mechanical 
insecticide and absorbents, to dynamite [140]. The ornamentation of the diatom frustule has 
been scrutinized carefully, and in nanotechnology it has e.g. a possible application in production 
of solar panels [148]. The frustule is also suggested to have medical application. Due to the 
pores in the biosilica and the possibility to be modified to bind with antibodies there are studies 
on using diatom frustules as drug delivery systems to direct drugs directly to the target. In that 
way it is possible to deliver drugs known for low solubility or low uptake by oral administration 
[149, 150].  
The potential of diatoms as a source of commercial products is without doubt great, not only in 
terms of their nutritional content but also bioactivity and the use of their silica shell in 
nanotechnology. Publications that deal with diatom physiology and ecology is abundant, but 
comprehensive knowledge of the production of bioactive compounds and secondary 
metabolites under various cultivation conditions is largely lacking. The present PhD project 
was carried out with this in mind, trying to take a step further on the road to a greater 
understanding of the biochemistry and bioactivity of P. glacialis and how well the species 
respond when introduced to new environmental conditions.  
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2 Materials and Methods 
2.1 The carbon capture and utilization (CCU) project 
This PhD was conducted as part of a carbon capture and utilization project. The project is a 
collaboration between the Arctic University of Norway (UiT) and one of the largest ferrosilicon 
producers in Norway, Finnfjord AS.  The aim of the CCU project is to mass cultivate nutritious 
diatom biomass by sequestering CO2 directly from the factory fume (Figure 7). Inherent of the 
project was also monitoring of algae growth rate, cultivation environment, chemical 
composition of the biomass, cytotoxicity but also to detect bioactivity that could be exploited 
for nutraceutical and pharmaceutical purposes. What affects the bioactivity and biochemistry 
of the diatoms is quite beneficial to investigate as it can aid in the research towards finding the 
optimal growth conditions for high quality biomass. As a part of the CCU project, the main 
focus of this thesis has therefore been the investigation of the bioactivity of the marine diatom 
Porosira glacialis and assessing how bioactivity can relate to the cultivation environment.  
Figure 7: Overview of mass cultivation pipeline at Finnfjord AS. Figure: R. Osvik  
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2.2 Experimental pipeline  
The experimental work included in this project was diverse and involved collection of diatom 
stocks during research cruises in open Arctic waters and polar ice, large-scale algae cultivation, 
bioactivity testing, metabolomic analysis and isolation of bioactive compounds in the 
laboratory. The two large-scale cultivation experiments have been based on applying stress 
factors, both abiotic and biotic, to the diatom monocultures of P. glacialis to investigate if stress 
would induce changes in the bioactivity or biochemistry of the diatom biomass. An overview 
of the cultivation and further workflow can be seen in Figure 8. This shows the process of 
cultivation, harvest, bioactivity testing, metabolomic analysis, and finally isolation of potential 
bioactive compounds in the biomass.  
MONOCULTURE
POROSIRA GLACIALIS
LIGHT, TEMPERATURE AND NUTRIENTS
CHANGING CULTIVATION 
CONDITIONSNORMAL GROWTH 
CONDTIONS – CONTROL 
CULTURE 






BIOACTITIVY AND TOXCICITY SCREENING AND COMPARISON 
(PAPER I AND II)
METABOLOMIC FINGERPRINT ANALYSIS AND COMPARISON 
(PAPER II)
ISOLATION AND CHARACTERIZATION OF BIOACTIVE COMPOUNDS 
(PAPER III)
Figure 8: Schematic illustration of the workflow leading to paper I, II and III in this PhD 
project. Figure: R. Osvik  
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2.3 Species selection and monoculture maintenance 
Around 16,000 species of diatoms are currently described [16]. Thus, there is a formidable 
number of species to choose from. Species selection is often based on specific traits, either 
morphological, ecological or biochemical. The microalgae research group at UiT has been 
working with diatoms for decades, collecting, isolating, cultivating and analysing numerous 
species, gaining experience with a variety of different diatoms. This groundwork has eventually 
led to selecting a panel of “species of interest” for more in-depth analysis. These are species 
that have shown promising results in terms of mass cultivation, nutrient content and possible 
bioactivity. The marine temperate diatom Porosira glacialis (Grunow) Jørgensen (strain 201) 
(Figure 9) is one of those species of interest and has been the subject of this PhD thesis. 
The original culture 201 used throughout this project was isolated as a single cell from a water 
sample collected near the ice edge south east of Svalbard (76°27.54 N; 33°03.54 E) during a 
scientific expedition with R/V Helmer Hanssen in May 2014. Taxonomic identification of the 
species was done based on morphological traits of the cell and genetic characters [151, 152]. 
The initial identification was done using inverted light microscopy. Later the identification was 
confirmed by Uradnikova [152] by electron microscopy and DNA barcoding using the rbcL 
gene of the chloroplast as a marker. Species isolation was performed manually using elongated 
Pasteur pipettes and serial dilution. Frequent examination of cultures in the microscope was 
done to ensure there is no contamination of other phytoplankton species.  
P. glacialis is a temperate species often found along the coast of Norther Norway, and along 
the ice edge in the Barents Sea during the spring bloom. It can handle temperatures as low as -




2 ºC [153]. It is also one of the larger diatom species, as the diameter of the centric silica frustule 
often exceeds 30 µm. The size gives them certain advantages in cultivation as they are easier 
to harvest than smaller species (Stokes law). Many diatom species such as those belonging to 
the genus Chaetoceros and Skeletonema are known to form long chains, P. glacialis, on the 
other hand, mostly appear as single cells but can sometimes be seen in pairs or shorter chains 
of 4-6 cells (Figure 9). The frustule does not have a connective thread but rather many thin setae 
that interlocks keeping the cells close to each other. Monocultures of P. glacialis strain 201 has 
been kept in the strain collection at the Norwegian College of Fishery Science at UiT since it 
was isolated in 2014.  
2.4 Mass cultivation of the diatom Porosira glacialis 
Proper environment and cultivation conditions are essential for a successful cultivation of 
microalgae. The conditions can be adapted to the purpose for the cultivation, maximum growth 
rate, optimal lipid production, pigment analysis or bioactivity testing. When performing mass 
cultivation, it takes place at much higher biomass concentrations than in the sea under natural 
bloom conditions. This calls for large focus on sufficient C for biosynthesis, i.e. CO2 well above 
natural air and sea concentrations, as well as that light easily become a scarce commodity here. 
A change in the cultivation conditions can also lead to changes in the quality of the biomass, 
and the biochemistry of the diatoms, e.g. it is known that N-starvation can lead to an increase 
in concentration of LC-PUFA [153-155].   
The biomass of P. glacialis for this PhD project was cultivated at a pre-industrial size test 
cultivation facility. The photobioreactors (PBR) used are open vertical column airlift PBRs 
located outside. Material for paper I and II were cultivated in two 6,000 L PBRs, one made of 
steel and one fiberglass. A 300,000 L fiberglass PBR were used to produce the material for 
paper III. The overview of the cultivation process is shown in Figure 8. All cultivation 
experiments started with stock cultures of P. glacialis strain 201 (20 L) kept in incubators at 
14:10h light:dark cycle with scalar irradiance at 30 µmol quanta m-2 s-1 and 4 °C. The cultures 
were diluted as the concentration of cells increased, until the volume became high enough to 
be transferred to the larger PBRs. This was a step-by-step process from 20 L inoculum to 2 x 
600 L before transferring to 6,000 L PBR and adjusting concentration of cells. The start 
concentration of cells L-1 in the monocultures was based on the type of experiment to be 
conducted (for details on the cultivation process for each experiment se paper I, II and III). The 
diatoms were grown in semi-continuous cultures; harvesting cultures at a predetermined cell 
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concentration and refilling with filtrated sea water and replenish with nutrients to reach the 
starting point. Continuous mixing of the culture to avoid settling of cells and to facilitate even 
nutrient distribution was done by bubbling air and/or factory smoke from the bottom of the 
PBRs. The cultivated biomass was harvested by draining culture from the bottom of the PBRs, 
directing it through a continuous centrifuge to remove all access water leaving P. glacialis as a 
thick paste. The harvest and de-watering process are easier when the cells are larger as they do 
not clog membranes as fast as the smaller sized species and are easier to centrifuge. Diatoms 
have a high concentration of polyunsaturated fatty acids making the biomass prone to oxidation; 
hence the samples were immediately frozen and stored at -80 °C to avoid degradation. 
2.4.1 Introducing stress factors  
Changing cultivation conditions by introduction of stress factors, which in turn could trigger a 
change in biochemistry or production of interesting secondary metabolites has been termed 
“One strain many compounds” (OSMAC) [156]. This method is based on the discovery that 
microorganisms harbour “silent gene clusters” which are not expressed under normal, and non-
stressful conditions [157]. Any deviation from “normal” and optimal growth conditions may 
alter the biochemistry of an organism. Changes in temperature, CO2 or pH, inorganic nutrient 
concentration and composition, competition or grazing stress may trigger production of 
secondary metabolites with attractive bioactivity.  
Change in cultivation conditions were introduced in monocultures of P. glacialis in paper I and 
II. In paper I, two identical cultures of P. glacialis were cultivated in parallel, where one of 
them were supplied with excess CO2 in the form of factory fumes. All other parameters 
(temperature, nutrient supply and irradiation) were kept as similar as possible and the only 
difference between them were the addition of factory smoke CO2. In the second experiment 
(described in detail in paper II), biotic stress factors were introduced to a monoculture of P. 
glacialis in the form of grazing zooplankton. When harvested, the zooplankton was removed 
from the culture and only the diatom biomass retained for further analysis. A monoculture of 
P. glacialis was used for comparison. The introduction of both abiotic and biotic stress factors 
in the cultivation process of P. glacialis facilitates the possibility to see how susceptible this 
species is to changes in the environment.  
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2.5 Extraction and sample preparation 
The first step of uncovering the bioactive potential of a marine organism is the extraction of the 
biomass. Which extraction method to use should first be based on the type of biological material 
as well as the nature of the desired compounds [158]. Also, often the target compound(s) are 
unknown, and the aim is to extract as much material as possible to be able to do a broad range 
of testing and chemical analysis without running out of extract. A common method to use is 
solid phase extractions, where the material is suspended in an organic solvent by choice. Water 
is removed by freeze-drying and if the material has tough cell walls, like plant material or some 
microalgae species it should be grinded using mortar and pastel to access the cell material. 
Solvents such as ethanol (EtOH) or methanol (MeOH) are common to use. The same method 
was applied in all experiments included in this thesis. Samples were first extracted using 
MilliQ-H2O removing salt and water-soluble compounds. Subsequently a 1:1 mixture of 
MeOH:dicholormethane (DCM) was used to generate the organic extract. Further detailed 
descriptions are found in paper I, II and III.  
2.6 Fractionation of extracts  
Marine crude extracts are quite complex chemical mixtures of neutral, acidic, basic, lipophilic, 
and amphiphilic compounds [159]. Testing extracts directly in bioassays might give skewed 
results due to masking of bioactive compounds, thus partitioning and pre-fractionation prior to 
testing of the extracts is recommended. Certain groups of compounds are undesired and 
considered less interesting when searching for bioactive compounds. The high concentration of 
salt in aqueous extracts from marine organisms can lead to false results in the bioactivity testing, 
especially if the assay is sensitive. In addition, it can be prone to bacterial or fungal growth 
which may seriously affect the analysis. The organic extract on the other hand contains highly 
lipophilic compounds which should be removed from the extracts, as they can be difficult to 
handle, and their chemical properties are not desired in drug development [160]. Liquid-liquid 
partitioning can be used as a method to remove the bulk of unwanted materials, e.g lipids, salt, 
sugars and surfactants [159]. 
Fractionation based on the chemical properties of the compounds is a traditional way of 
decreasing complexity of the extracts. Flash chromatography and high-performance liquid 
chromatography (HPLC) are both common methods to use in the initial separation. Flash 
chromatography is a method of separating a larger amount of extract, in gram quantities, over 
 
 22 
a short time [161]. This method is efficient and produce a manageable number of fractions. If 
the extract is separated into a too high number of fractions, one might experience that the active 
compounds are spread over several fractions decreasing the concentration to undetectable 
amounts. Flash chromatography is therefore a good method to use in the initial step of the 
purification of natural products. This method was used in paper I, II and III (details of method 
found in the papers) after a liquid-liquid partitioning of the extracts using hexane to remove the 
highly lipophilic compounds. In paper III, HPLC was used to re-fractionate Flash fractions that 
had shown activity in the first round of bioactivity testing. HPLC is also a type of column 
chromatography which typically handles smaller amounts of material than Flash 
chromatography, leading to higher degree of separation. The type of column, and column 
material is chosen based on how well the compounds in the extract are separated in the column, 
hence how well they can be collected without impurities [162]. Preparative HPLC combined 
with mass spectrometry is also one of the methods most often chosen for dereplication and 
further isolation of secondary metabolites [163, 164].  
2.7 Uncovering changes in the biochemistry of Porosira glacialis  
Changes in the biochemistry of a diatom due to changing cultivation conditions can be detected 
using different methods. One method is by investigating the species bioactivity and search for 
possible changes in the bioactivity due to the changing cultivation conditions. Although, not all 
changes can be detected in expressed bioactivity which makes it necessary to employ methods 
such as metabolomics for analysing all metabolites in the sample (paper II). 
2.7.1 Bioactivity testing 
When testing extracts or fractions in bioactivity assays it is possible to examine the response of 
whole organisms, tissues, cells or specific cellular targets. Bioassays using whole cells or 
organisms, where the measurement could be e.g. cell-survival, presence of biofilm or 
morphological changes are so-called phenotypic bioassays. Among these assays are cancer cell 
proliferation assays, where the measured parameter is the survival of the cells. In target-based 
bioassays the potential bioactive compounds are tested towards a single, specific target. This 
could be a gene or a molecular mechanism like e.g. enzymes, receptors or antioxidant activity 
[165]. In biodiscovery, bioassays are used to determine the bioactivity of the extracts, which 
might lead to the isolation of compounds with commercial potential. In the experiments in paper 
I and II, phenotypic bioactivity assays were used to uncover the potential activity of P. glacialis, 
but also to investigate whether the addition of factory smoke, or the co-cultivation with 
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zooplankton triggered any changes in the production of bioactive metabolites. A panel of 
bioactivity assays were chosen for this purpose. A cancer cell proliferation assay against human 
melanoma (A2058) and human colon carcinoma (HT29) cell lines, and a cytotoxicity assay 
towards normal lung fibroblasts (MRC5). A sea urchin embryo development toxicity assay 
(Paracentrotus lividus) was used to assess the effect on invertebrate larvae. The antibacterial 
effects were investigated against both Gram-negative (Escherichia coli and Pseudomonas 
aeruginosa) and Gram-positive bacteria (Staphylococcus aureus, Enterococcus faecalis and 
Streptococcus agalactiae Group B), in addition to antibiofilm assay on Staphylococcus 
epidermidis. Details on the specific methods are found in papers I and II. Paper III focused on 
the antibiofilm activity found in the previous two studies. The bioassays used tested both 
activity of P. glacialis on the inhibition of biofilm formation and eradication of established 
biofilm by Staphylococcus epidermidis.  
2.7.2 Metabolomics  
Metabolomics is one of the emerging “omics” disciplines, seeking to investigate the biological 
mechanisms and processes of living organisms on every level: full genome sequencing 
(genomics), RNA transcripts and gene expression (transcriptomics) and metabolite profiles 
(metabolomics). Metabolomics is a method used to analyse a set of metabolites in biological 
samples such as cells, tissue, organs, fluids or whole organism. This is done to compare the 
metabolite profile or specific metabolites under optimal conditions versus non-optimal 
conditions, i.e. under stress, environmental impact, diseases or drug treatment [166]. When 
investigating the metabolome, one can use targeted metabolomics, searching for specific 
metabolites, and how they change in concentration or if they are present, or not. Another 
method, and the method used in paper II, is untargeted metabolomics, or metabolomic 
fingerprinting. Untargeted metabolomics aims at identifying the highest possible number of 
metabolites in the biological samples and compare their expression. Nuclear magnetic 
resonance (NMR) spectroscopy and mass spectrometry (MS) are common tools in metabolomic 
analysis, both having their advantages and drawbacks. [166] MS is more sensitive than NMR 
but requires more pre-fractionation and separation using e.g., HPLC or ultra high performance 
liquid chromatography (UPLC), compared to NMR, where samples can be analysed directly. MS 
is the most used technique, and the most comprehensive of the two. In many cases, the choice 
of analytical platform depends on what the researcher is comfortable with. Metabolomic 
fingerprinting with HR-MS was used in paper II to investigate changes in the metabolite 
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composition or concentration when P. glacialis was exposed to grazing pressure. Detailed 
description of the system used, and the data analysis is found in paper II.  
2.8 Isolation and structure elucidation of bioactive compounds  
2.8.1 Isolation  
When interesting bioactivity is detected in extracts or fractions, the next step in the process is 
dereplication to investigate whether this is a compound previously found. Indication of new 
and interesting chemistry leads to the isolation of the specific compound. Preparative HPLC 
was used for the initial isolation of compounds from P. glacialis. Column materials were 
carefully selected to give optimal separation of the target compounds, making them easier to 
isolate from the complex extracts. The preparative HPLC was used in combination with mass 
spectrometry to collect compounds based on mass. Isolation of secondary metabolites is often 
based on testing several columns, elution gradients and selecting the right trigger method to be 
able to collect the desired compounds from the extracts. Collection of desired compounds can 
either triggered by mass, or by using timed events based in retention time. The collection 
method is chosen based on which eliminates possible impurities in the best possible manner. 
Isolation of compounds from P. glacialis was performed in three steps of separation and 
purification. Initial isolation was performed using a preparative HPLC-MS system with a 600 
HPLC pump, 3100 mass spectrometer, 2996 photo diode array detector and a 2767 sample 
manager (Waters). The column used was Waters Xterra Prep MS C8 10 µm, 
10x250mm column as it showed best separation after the first injection. The second and third 
step of isolation was performed using a semi-preparative HPLC system coupled to a PDA 
and QDa-MS with a Sample-manager FTN-R, Quaternary-solvent-manager (HPLC-pump), 
isocratic solvent manager, column-oven, QDa detector, a 2998 PDA detector and a fraction 
manager, all ACQUITY-ArcTM components. The column used was a Waters AtlantisTM T3 3 
µm, 3.0×150 mm C18 column. The gradient elution time was adapted based on a trial-and-error 
manner to adjust for best possible separation (details in paper III) 
2.8.2 Structure elucidation  
Fractions displaying activity and the isolated compounds from P. glacialis were all analysed 
using high resolution mass spectrometry (HR-MS). MS is a technique measuring the mass-to-
charge ratio (m/z) of gas phase ions. A MS system consists of an ion source, a mass analyser 
and a detector. There are a variety of different mass analysers. In this thesis, both for 
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metabolomic analysis and analysis of bioactive fractions/compounds, an UPLC system coupled 
to a PDA Detector and a VION IMS-qTOF, using electrospray ionization (ESI) (details in paper 
II and III). In a time-of-flight (TOF) mass filter, the ionized molecules are accelerated by an 
electric field into the analyser which is a vacuum chamber. The ions are separated by m/z as the 
lighter arrive and are detected before the heavier ones [167]. It is a reliable tool for accurate 
mass measurement, which allows for the elemental composition of the compounds to be 
calculated. Nuclear magnetic resonance spectroscopy (NMR) was used in the structure 
elucidation of isolated compounds from P. glacialis. Experiments and elucidation were 
performed by Kine Ø. Hansen and Johan Isaksson (UiT). NMR spectroscopy is a common tool 
used to study the structure and bonding of molecules by using the magnetic properties of atomic 
nuclei. Commonly examined nuclei are 1H and 13C which will give information about the 
physical and chemical properties of a molecule [168]. To elucidate the structure of a complex 
compound, a combination of several NMR experiments, as well as other analytical data, are 
often required. 
2.9 Software  
A set of software packages were used to analyse and visualize all the results. All figures and 
plots presenting bioactivity data in paper I, II and III were made using Prism 8 for Mac 
(GraphPad Software Inc.). Statistical analysis in paper I used Prism 8, while in paper II 
statistical analysis of data was done by running chi-square tests in Excel for Mac 2020 version 
16.36. The map in paper II was made using with Maps version 3.1.1. in R version 3.3.2. 
Metabolomics data was analysed, and statistical presentations and plots were made using 
EZinfo v.3.0.3.0 (Umetris ab) and Progenesis QI v.2.4 (Nonlinar Dynamics). UNIFI 1.9.4 
software (Waters) was used for acquisition and analysis of HR-MS data. Figure 3 and 8 in the 
thesis introduction and materials and methods chapter was drawn using Procreate version 5X 5 
(Savage Interactive Pty Ltd, Hobart, Tasmania) on an iPad Pro.  
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3 Aim of thesis 
The work in this thesis has been a part of a carbon capture and utilization (CCU) project. The 
aim of the cultivation studies was to investigate the effects of large-scale cultivations on extracts 
of diatoms and to understand how the marine diatom Porosira glacialis responded to changes 
in cultivation conditions. The study was designed to assess how cultivation conditions could 
affect the biochemistry and bioactivity of P. glacialis by investigating the response to changes 
in both abiotic and biotic environmental factors by using the OSMAC “one strain many 
compounds” cultivation method. Further, another objective was to isolate and characterize 





4 Summary of papers 
4.1 Paper I  
 
Bioactivity of a marine diatom (Porosira glacialis (Grunow) Jørgensen 1905) cultivated with and 
without factory smoke CO2. 
Renate Døving Osvik, Jeanette Hammer Andersen, Hans Christian Eilertsen, Anne-Marie Geneviere, 
Espen Holst Hansen 
Two cultures of the temperate marine diatom Porosira glacialis were cultivated in parallel in 
6,000 L photobioreactors under the same cultivation conditions (temperature, light and 
nutrients), except one culture received excess CO2 from factory smoke, while the other received 
pressurized air (Figure 1, paper 1). The harvested biomass was freeze dried, extracted and 
fractionated before being tested in a panel of bioactivity assays: antibacterial (Staphylococcus 
aureus, Escherichia coli, Pseudomonas aeruginosa. Escherichia faecalis and Streptococcus 
agalactiae), antibiofilm (Staphylococcus epidermidis), anticancer (human melanoma and 
human colon carcinoma), cytotoxicity (normal lung fibroblasts) and sea urchin toxicity assay 
(Paracentrotus lividus). This to assess the bioactivity of the biomass, and to reveal whether the 
direct addition of factory smoke would trigger changes in the bioactivity.  
The study revealed bioactivity in antibiofilm assay and in both anticancer assays, but the 
addition of factory smoke CO2 did not trigger any changes in the bioactivity compared to the 
control. There was no activity found in the cytotoxicity assay against normal lung fibroblasts. 
The results from the sea urchin toxicity assay confirmed previously reported diatom toxicity 
against sea urchin larvae development. Although toxicity was detected, the addition of factory 
smoke did not increase toxicity showing that the bioactivity and toxicity of P. glacialis is not 
affected by the addition of factory smoke. These results indicates that the factory smoke can be 
used as a safe source of CO2 in the industrial production of diatom biomass.  
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4.2 Paper II 
  
Adding zooplankton to the OSMAC toolkit: Effect of grazing stress on the metabolic profile and 
bioactivity of a diatom.  
Renate D. Osvik, Richard A. Ingebrigtsen, Fredrika Norrbin, Jeanette Hammer Andersen, Hans 
Christian Eilertsen and Espen Holst Hansen 
 
“One strain many compounds” (OSMAC) is a term in microbiology where changes in 
cultivation conditions is applied to trigger production of bioactive compounds. OSMAC is not 
widely applied in microalgae cultivation, hence the aim of this paper was to assess the effect of 
co-cultivation of diatoms and zooplankton.  
 
A monoculture of Porosira glacialis was cultivated over a period of 5 days before half of the 
culture was harvested. A mixed sample of zooplankton was collected in a bay area close to the 
cultivation facility. The zooplankton sample was added to the P. glacialis culture and cultivated 
for 5 days, and then the diatom biomass was harvested by sieving out the zooplankton. The 
cultivation was repeated twice (Figure 9, paper II). The harvested biomass was freeze dried, 
extracted (aqueous and organic), and fractionated. The extract was analysed using LC-MS to 
assess the metabolomic differences between the cultivation conditions. A set of bioactivity 
assays (anticancer, antibacterial and antibiofilm) was run to investigate whether the presence 
of zooplankton changes the bioactivity of Porosira glacialis.  
 
Analysis of the metabolomic profile revealed differences between the monoculture and co-
culture. Markers contributing most to the differences between the samples were identified to be 
phaeophytin (monoculture) and carotenoids (co-culture). Bioactivity was found in all bioassays 
performed. Co-cultivation had no effect on the antibacterial activity. The cytotoxicity assay on 
normal lung fibroblasts showed elevated toxicity by the co-culture extract, thus revealing a 
possible higher toxicity as a result of grazing pressure.  
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4.3 Paper III  
 
Antibiofilm activity of compounds isolated from temperate diatom Porosira glacialis 
Renate Døving Osvik, Kine Østnes Hansen, Richard Andre Ingebrigtsen, Jeanette Hammer Andersen, 
Espen Holst Hansen  
 
The temperate diatom Porosira glacialis has revealed antibiofilm activity in several studies, 
which motivated an in-depth investigating of the activity with the aim of isolating compound 
responsible for the activity. P. glacialis was cultivated in a 300 000 L vertical column airlift 
photobioreactor. The biomass was extracted using DCM:MeOH, fractionated using Flash-
fractionation and preparative HPLC. Flash, and HPLC fractions were tested for inhibition of 
biofilm formation and eradication of established biofilm by Staphylococcus epidermidis. In 
addition, HPLC-fractions were tested for antibacterial activity in a growth inhibition assay.  
 
Two flash fractions were found to inhibit biofilm formation. These two were further 
fractionated using preparative HPLC and tested for inhibition of biofilm formation and for 
eradication of established biofilm. Out of 80 fractions tested, 6 fractions inhibited formation of 
biofilm wile 3 fractions were able to remove established biofilm. Inactive and active fractions 
were analysed using HR-MS to find compounds unique to the active fractions. This 
investigation resulted in the isolation of 6 compounds found in or in relation to the active 
fractions. Out of the 6 compounds, three were evaluated to be pure enough for NMR analysis, 
and two of them resulted in compound structures. All 6 collected compounds were tested for 
inhibition of biofilm formation. Two compounds were able to inhibit biofilm formation: methyl 
3-hydroxyoctadecanoate, a pheophorbide like compound, both known compounds. A third 
compounds showed activity, though no structure was obtained. This study is the first to report 
on antibiofilm compounds isolated from P. glacialis as well as the first report on antibiofilm 








5 General discussion 
Increasing CO2 emissions are one of the main forces driving the anthropogenic climate changes 
we are experiencing today. The rate of global warming will increase rapidly unless we reduce 
emissions and make attempts to remove CO2 from the atmosphere [169]. Carbon capture and 
storage strategies (CCS) has received much more focus and investment by the Norwegian 
government than other strategies to reduce CO2 emissions [170]. Carbon capture and utilization 
(CCU) using photoautotrophic microalgae to convert CO2 to organic biomass is emerging as a 
feasible CO2 sequestration strategy [99, 105, 171-173]. We know that marine diatoms are 
responsible for at least 25 % of the inorganic carbon fixed in the ocean annually, which makes 
them natural candidates for biological CCU [3, 5]. Connecting large-scale cultivation plants to 
industries with high CO2 emissions can lead to promising CCU symbiosis, resulting in a 
reduction of CO2 emissions and production of biomass for commercial applications. Diatom 
biomass has a variety of applications based on their nutrient content. P. glacialis is rich in LC-
PUFAs which is in-demand in the Norwegian aquaculture industry, making it a potential source 
of sustainable feed ingredient production [153, 155]. In addition, P. glacialis could also be a 
potential source of other interesting compounds with commercial applications based on the 
discovery of bioactivity in this study.  
5.1 Large-scale cultivation  
In large-scale production of diatoms for carbon capture, the CO2 must be added to the algae 
cultures in the most feasible and economically viable way. One of the strategies is to add CO2-
rich industrial emissions directly from point sources to the PBRs, skipping any extra 
purification process of the factory smoke. Due to laws and regulations regarding pollution and 
air quality, companies are required to purify all emissions (smoke and water) to ensure that 
harmful substances are set within limit values [174]. Nevertheless, the factory smoke still 
contains large amounts of CO2, in addition to a substantial amount of NOx, SO2 and trace 
metals. In addition, an industrial environment is never completely clean, hence dust and 
particles might mix with the microalgae culture when cultivating in open PBRs. The direct use 
of smoke in this manner might affect the diatoms growth rate, physiology, toxicity and 
biochemistry due to changing cultivation conditions. A large-scale cultivation study thus is 
necessary to investigate the response of the diatom. Our cultivation facility enables mass 
cultivation of marine diatoms, using factory smoke as a source of CO2. The facility is under 
constant development and upscaling. Since the spring of 2015 the PBRs have expanded in 
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volume from 6,000 L to 300,000 L. Large-scale experiments with marine diatoms provides an 
excellent opportunity to investigate growth requirements, growth rates and biochemistry of the 
biomass. All the biomass of P. glacialis used in this project has been cultivated at the large-
scale facility in order to reflect the “real life” conditions of commercial production, not only 
the optimal laboratory conditions. When cultivating diatoms outdoors, using open cylindrical 
PBRs there are challenges that needs to be taken into consideration regarding the consequences 
they might have for further investigation of the biomass. Such challenges can be due to climate 
e.g. temperature (air and ocean), precipitation and variation in natural irradiation, or 
contamination by bacteria, fungi or other species of microalgae. Keeping a large-scale culture 
axenic is near impossible. Sustaining a sterile culture requires closed systems, filtration and 
maintenance which is difficult even in small volumes in the laboratory. On a large scale, this 
will be far too expensive and laborious to be economically viable. However, as discussed in the 
introduction the bacteria present usually don’t cause any harm to the diatom culture, and some 
of them are even beneficial [31, 175]. Heavy bacterial contamination is easy to detect in the 
microscope, as the concentration in bacteria increase and the diatom culture looks unhealthy 
(as shown in Figure 10). During exponential growth, the diatom culture looks healthy (Figure 
10, left side) and there are few dead cells in the culture. When the number of broken/dead cells 
is low there is less organic carbon available for bacterial growth, hence the bacterial 
concentration is often low and under control. Some diatom species have antibacterial activity 
which was also found during the present study [176]. Such activity may be one of the reasons 
why its observed that the diatoms keep the concentration of bacteria on a non-harmful level in 
the culture. It’s important to keep in mind that we work with organisms that, in nature, have a 
Figure 10: P. glacialis in culture. Healthy monoculture to the left, contaminated culture on the right. Contamination caused 
by flagellates, bacteria and possible fungi (chytrid). Photo: Gunilla K. Eriksen 
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close relationship with other planktonic organisms. Diatoms have shown to depend on some 
bacterial species, thus non-axenic cultures should be accepted as long as the diatoms are healthy 
[44, 45].  
Searching through literature on the bioactivity of marine diatoms reveal that the majority have 
been focusing on species cultivated in small batches under laboratory conditions [101, 177-
179]. Cultivation in small volumes (<100 L) in the laboratory renders full control of the applied 
conditions by using temperature regulated incubators, artificial lighting and high-quality 
nutrient supply, e.g. Guillard’s F/2 marine water enrichment solution. The sea water used for 
cultivation can be autoclaved or one can use artificial sea water, and the air inlet can be filtrated 
to exclude contamination of the monocultures keeping them axenic, or close to axenic. These 
conditions are perfect for curating monoculture collections, and for conducting small scale 
experiments in the initial phase of the biodiscovery process. However, in order to produce 
diatom biomass for commercial applications, scaling up from the laboratory to large-scale 
cultivation is needed [100]. When scaling up to large-scale cultivation systems certain changes 
in infrastructure must be implemented to increase production yield, at the same time as the 
control over the cultivation conditions is maintained [101, 177-179]. It is impossible to maintain 
laboratory conditions in large scale, outdoor PBRs, but is a trade-off made to keep up with 
viable production while keeping expenses and workload at a manageable level. 
Diatoms are known to alter their bioactivity and biochemistry according to changes in 
environmental conditions: temperature [180], irradiation [129], nutrient supply [125], and 
presence of other planktonic organisms [86]. Some changes can be desired, such as increased 
LC-PUFA concentrations, while other changes are unwanted e.g. toxin production. Cultivated 
diatom biomass to be used in food, feed or other applications for human consumption must be 
safe and of high quality. All variations and unwanted changes in the biomass which may arise 
from a changed environment must be uncovered. Scaling up production to a commercial scale 
will inevitably result in other cultivation conditions than those found in the lab [100]. Hence, it 
is highly important to acquire information on the robustness of the algae to be cultured for 
commercial purposes, in this case P. glacialis. Few papers are published on the process of 
scaling up to a level of commercial production. Often, industrial partners are included, and 
results can be protected by intellectual property rights, resulting in less publications [100].  
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5.2 Species selection  
Choosing the right strain for mass cultivation is key, but how does one choose among thousands 
of species? There are numerous factors to consider when choosing the right species or strain; 
growth-rate, desired end-product, productivity, harvest and extraction [181]. To find the 
optimal species for large-scale cultivation, one must assess the species ability of high 
production under the conditions that can be provided at the cultivation facility. Optimal 
growth temperature can sometimes be reflected in where you find the species in the ocean, 
whether its tropical, temperate or Arctic regions. P. glacialis is described as a cold-water 
species. It is often found during the spring bloom in Northern Norway and is a common species 
to find in the ice edge bloom in the Barents Sea and Arctic oceans, the latter region being the 
collection site of this specific strain. Needless to say, it grows well at low temperatures making 
it a perfect candidate for large-scale production in colder areas. Experience with P. glacialis 
both in the laboratory and in the field has shown us that it grows fast, has a wide tolerance of 
growth temperatures and is easy to harvest due to its cell size [153]. The cultivation experiments 
in paper I, II and III were all conducted during winter (December – March). The air 
temperatures being - 12°C on certain days, and the water temperature was below zero during 
the cultivation. Yet, P. glacialis reached exponential growth (Fig. 2 in paper I and Fig. 1 in 
paper II) and showed no signs of struggling based on the visual control of the cultures. This 
adaption to low temperature makes it possible to cultivate through the changing seasons in 
Northern Norway. Most large-scale production facilities are located in areas with warm climate 
and with little seasonal variations. Several of the traditional species for large-scale production 
have an optimal growth temperature between 20 and 40 °C. Hence, it might seem counter 
intuitive to produce microalgae above the Arctic Circle where the sun is below the horizon for 
two months every winter, and to aim for year-round production. Still, the closeness to the ocean, 
industry providing CO2 and large areas of otherwise non-arable land, are all factors contributing 
to a viable production of diatoms in Northern Norway [90]. A study by Matsumoto et al. 
suggested using different species for different seasons for production of biomass to overcome 
the struggle of seasonal changes [98]. This is of course a possible solution, although finding 
species tough enough to withstand variations the seasonal variation, will improve and simplify 
the production. For cultivation in Nordic countries it is natural to search for species found 
naturally on higher latitudes [90, 182]. Using cold-adapted species, like P. glacialis, will 
increase the likeliness of success for year-round cultivation using one species, as the optimal 
conditions differ from the traditional species cultivated on lower latitudes. Although how a 
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species acts under optimal conditions is one thing, it is also important to understand the 
versatility of a species, and how it reacts to upscaling and less optimal conditions. 
5.3 Changing cultivation conditions  
The cultivation studies in paper I and II were designed to investigate how P. glacialis responds 
to changing abiotic and biotic factors in the environment. This was done with the aim of further 
understanding how P. glacialis can be treated in large-scale cultivation in terms of cultivation 
conditions, and how the species react if the conditions change. To investigate this, a method 
used in biodiscovery termed OSMAC  “One strain many compounds” was applied [156]. The 
method is well-regarded and widely used in the search for secondary metabolites in terrestrial 
prokaryotes and fungi, although the use is increasing in marine biodiscovery [157]. In general, 
diatoms are poorly represented among the studies on bioactivity and marine natural products. 
The OSMAC approach have not been used extensively to look for new activity in diatoms, but 
some studies have looked at their chemical response to changing environments. Some of these 
studies have been conducted at Marbio – UiT [125, 129, 180]. Those studies have shown that 
temperature, light intensity and nutrient availability can change the bioactivity of diatoms. With 
those results in mind, it was natural to hypothesize that diatoms might change their bioactivity 
when cultivated using direct addition of factory smoke in the CCU project. Adding factory 
smoke to the monoculture, changes the abiotic factors in the environment (paper I). The next 
to study was to find out whether biotic factors, in the shape of zooplankton, could alter P. 
glacialis bioactivity and metabolite expression (paper II).  
5.3.1 Toxicity and bioactivity profiling  
All samples of P. glacialis tested (paper I, II and III) were bioactive, which could be relevant 
for commercial application. In paper I, two cultures of P. glacialis were cultivated in parallel, 
keeping all cultivation parameters similar (temperature, nutrient supply and irradiation 
intensity). The only difference between the two were the direct addition of factory smoke as a 
source of CO2 in one. Pressurized air was used in the other to secure similar mixing by air 
bubbles. In paper II, the concept was similar although the change in cultivation conditions was 
not based on changing the abiotic factors, but rather by introducing a change in the biotic factor 
by co-cultivating P. glacialis with zooplankton. The samples harvested from both studies were 
tested in a panel of bioactivity assays to assess the bioactivity of P. glacialis and how the species 
responds to abiotic and biotic changes. Previous bioactivity studies that included P. glacialis 
has shown activity against human melanoma (A2058) [129], which was confirmed by the 
 
 35 
results in paper I and II. Anticancer activity towards human colon carcinoma (HT29) was found 
in both studies (Figure 11). Anticancer activity in other diatom species have been found in 
several studies [124, 125, 127, 128, 183]. In studies where dereplication of active fractions has 
taken place, PAHs has been shown to be the active compound, although these have not been 
detected in any of the active fractions analysed during the present study [128]. A few diatom 
species display antibacterial activity [48], and there are studies showing that diatoms synthesize 
some fatty acids with antibacterial effect e.g. EPA [47, 184]. Antibacterial activity was found 
against Streptococcus agalactiae (paper I and II) and Enterococcus faecalis and Staphylococcus 
aureus (paper III). The extracts also inhibited formation of biofilm of Staphylococcus 
epidermidis (Figure 11). A literature search has revealed that this is the first evidence of 
antibacterial activity by P. glacialis.  
Apart from the bioactivity, the toxicity of the samples was tested to investigate whether the 
changing cultivation triggered production of toxic compounds. In the cultivation study using 
factory smoke (paper I), two phenotypic toxicity assays were chosen: a cell viability assay using 
normal lung fibroblasts (MRC5) and sea urchin embryo development assay (Paracentrotus 
lividus). There was no activity towards the lung fibroblast, while the sea urchin development 
assay revealed toxicity. Considering all published papers showing teratogenic effect of diatoms 
on zooplankton species, and previously found specific toxicity towards P. lividus sea urchins 
these results were not surprising [57, 59, 68, 70, 71, 74, 80, 185-188]. In the co-cultivation 
study (paper II), toxicity was tested using normal lung fibroblasts, and here toxicity was 
detected in the organic fractions.  
  
Figure 11:  96-well Nunc plates shows results from antibiofilm(a) and anti-cancer (b) bioassays. The clear wells in (a) and the 
yellow-coloured wells in (b) shows fractions in which biofilm formation and cancer cell growth has been inhibited, respectively.  
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In terms of the response of P. glacialis to changing the abiotic and biotic cultivation conditions 
we can see that the direct addition of factory smoke as a source of CO2 has no obvious effect 
on the bioactivity of the biomass. The factory smoke does not trigger any toxicity towards 
human cells, as the results from the toxicity assays show the same pattern in both cultivation 
conditions. Neither does it seem to alter the bioactivity of the samples since the antibacterial 
and antibiofilm activity is preserved. Although there are compounds present that lead to 
developmental failure in P. lividus, there is no increased toxicity when P. glacialis is cultivated 
using factory smoke as a source of CO2. These results show that P. glacialis is quite resistant 
to these abiotic changes in the environment, and that it does not trigger an elevation in 
cytotoxicity. The presence of grazing zooplankton on the other hand had an effect on the 
toxicity of P. glacialis. When co-cultivated with zooplankton, the biomass showed increased 
toxicity against normal lung fibroblasts (paper II, Figure 4). Studies have shown that chemical 
cues released by copepods, termed copepodamides, influence diatoms. Copepodamides can 
induce morphological changes, such as chain-reduction in S. marinoi, as well as increased 
production of domoic acid [86, 189]. As the neither the zooplankton, nor the exudates in the 
cultivation medium was analysed, we cannot say whether copepodamides were present, but a 
thought. Analysis using UPLC-HR-MS was performed on the active fractions, and 
identification of prominent peaks in the chromatogram revealed signals corresponding to the 
primary metabolites: chlorophyll derivatives, carotenoids and phosphocholines, which are all 
known to have bioactivity [156, 157, 190, 191]. This can be part of an explanation of the 
increased toxicity, although finding obvious differences between the active and non-active 
fractions proved to be difficult, as the majority of the compounds seemed to be present in both 
samples.  
Comparing the studies in paper I and II it is obvious that the toxicity towards MRC5 has 
changed in general, as there was no detected toxicity in paper I. In a study by Ingebrigtsen et 
al. [130] extracts of P. glacialis was tested against MRC5, and there was no toxicity. An 
explanation is that the cytotoxicity is connected to the aforementioned primary metabolites 
which are present under all cultivation conditions, but in varying concentrations making the 
chemical analysis more difficult to interpret. These compounds are not normally cytotoxic, but 
at high concentrations i.e. in organic extracts they might have an effect and non-specific 
bioactivity against the normal lung fibroblasts. Nonetheless, the variations in toxicity, shows 
that there is a need to monitor the toxicity of diatoms when cultivated for commercial 
production to ensure a safe and high-quality product.  
 
 37 
It also shows us that changing the biotic factors can be used as a method to trigger a biochemical 
response in P. glacialis, enabling OSMAC to be a workable tool in diatom biodiscovery.   
Secondary metabolites are not always present in the cell. Full genome sequencing has over the 
last two decades revealed “silent” gene clusters to be possible producers of secondary 
metabolites in microorganisms. These gene clusters can produce secondary metabolites when 
the organism is exposed to stressing factors e.g. nutrient limitation or competition, but are left 
silent when growth conditions are optimal [156, 157, 190, 191]. Secondary metabolites are 
often produced by organisms to enhance their chances in competition with other. Plants produce 
secondary metabolites as a defence against herbivores, or as colourful pigments to attract 
pollinators [111]. Bacteria produce antimicrobial compounds in the presence of competing 
species [192]. Interactions with the surrounding abiotic and biotic factors shape organisms 
behaviour in terms of chemical ecology and which secondary metabolites they produce [111]. 
Many of these compounds have complex chemical structures, demanding energy from the 
producing organism. Without the presence of competition or environmental challenges, there 
might be no need using an unnecessary amount of energy. The production of secondary 
metabolites is therefore rendered silent, until needed. This again shows that laboratory 
conditions optimal for high growth rates, are not always the best for discovering novel 
secondary metabolites.  
5.3.2 The metabolomic fingerprint 
The current study and other published studies reveal that diatoms display a variety of interesting 
bioactivities: anticancer, antidiabetic, anti-inflammatory, antibacterial, antibiofilm [47, 124, 
129, 134, 139, 193-195]. Nonetheless, still a lot of information related to the chemical profiles 
of diatoms are missing [196]. Using untargeted metabolomics can be a way of obtaining such 
information and can be a valuable tool in the search for bioactive compounds. A metabolic 
fingerprint is a method where you do an analysis of the metabolites present in a sample at a 
given time, under the given conditions present when the sample was taken [197]. This method 
can be used to investigate the metabolic profile of an organism under what is considered normal 
growth conditions, versus deviating conditions. In paper II we investigated the metabolite 
profile of P. glacialis cultivated in monoculture, and then in co-culture with zooplankton.  
When analysing the metabolomics data, it was evident that there were differences in the 
metabolomic fingerprint between the two cultivation conditions. The markers contributing most 
to the difference between the monoculture and the co-culture were attempted identified (S-plot, 
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Figure 7, paper II). Identification revealed that the markers contributing most to the co-culture 
samples were carotenoids based on the elemental composition. The two most contributing 
markers elemental compositions coincide with halocynthiaxanthin (C40H54O4) and 
halocynthiaxanthin acetate (C42H56O5). Halocynthiaxanthin is known as a metabolite of 
fucoxanthin, isolated from sea squirts (Halocynthia roretzi). [198, 199] Fucoxanthin is a well-
known part of the diatom pigment profile, and a compound with a variety of bioactivities. [200-
202] The markers in the monoculture samples were identified as chlorophyll derivates: a 
pheophorbide like structure (C36H38N4O6) and pheophorbide b (C33H34N4O3). These 
identifications correspond to the prominent peak identified in the active fractions (chlorophyll 
derivates, carotenoids and phosphocholines) and could add to the possibility that the bioactivity 
in the cell viability assays is caused by these compounds). In higher plants, carotenoids are 
well-known antioxidants, and has shown to increase due to light-induced stress. Though there 
are no results backing this up, maybe it is possible that diatoms increase the concentration of 
antioxidants i.e., carotenoids in response to grazing-induced stress.    
It is also known that diatoms release metabolites into the environment. Some of these 
metabolites are known as infochemicals, or allelochemicals for communication between 
species, or influencing other planktonic species [200-202]. A study investigating the 
exometabolomic is often termed the metabolic footprint. Barfosky et al. [203] came up with a 
method to perform a metabolic profiling of exudates from Skeletonema marinoi and 
Thalassiosira pseudonana. The study found that the patterns of excreted metabolites varied 
significantly during the different growth phases. It is plausible to suggest that diatoms might 
also alter the exometabolism in response to environmental changes. This was not analysed 
during this PhD project, as the focus was on analysis of harvested diatom biomass. Though, it 
would be interesting to analyse exudates in the cultivation medium of P. glacialis in the search 
for secondary metabolites and novel bioactive compounds. This could be done by applying the 
method of Barofsky et al. [203] to investigate the exometabolomic of P. glacialis. This would 
also be useful information in the current CCU project, to obtain as much information as possible 
on the species of interest, but also to add information to the OSMAC study performed in paper 
II.  
The metabolic fingerprint analysis in paper II was performed on the same crude extract from P. 
glacialis that was used for Flash-fractionation and further bioactivity testing. The reason for 
this was that the results from the bioactivity assays and the metabolic fingerprint analysis could 
be compared to see whether the same changes could be seen using both methods. The use of 
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solvents, the handling of the material, and the freezing temperature will influence the samples. 
It is therefore important to decide on the method in advance and carry out the analysis based on 
the choices made. An important aspect, as stated previously, a large outdoor culture will never 
be axenic. Contamination due to other algal species is less likely due to the filtration of the 
water filtration. Bacteria on the other hand, will always be present. Although most bacteria in 
the sea water will be washed out during the harvesting process, there will still be some 
prokaryotes left in the biomass. The concentration of bacteria compared to P. glacialis in the 
analysed biomass is therefore low, but it must be considered.  
There is no doubt that metabolomics is a powerful method in discovering the rich, and yet 
unexplored source of metabolites, of which can harbour interesting commercial applications. 
Metabolomics can uncover changes in biochemistry not detected by bioactivity and toxicity 
assays. Although together form a helpful tool to understand the biochemical responses that 
might occur in diatoms when the abiotic and biotic environmental factors change. Using this to 
acquire new information on the species to be cultivated can improve large-scale cultivation 
systems and understanding how to treat the cultivated species for safe production of high-
quality biomass.  
5.4 Antibiofilm activity 
The antibiofilm activity was observed in all samples tested throughout the cultivation studies 
in paper I and II. This observation triggered an interest in further investigations of this activity 
(paper III). The antibacterial and antibiofilm activity is interesting as it is the first evidence of 
such activity in P. glacialis. Also, due the potential for commercial applications of such 
compounds and the benefits they bring to mass cultivation of diatoms. The fact that the 
antibiofilm activity was present in all three cultivation studies is valuable information. These 
results substantiate the claim that antibiofilm activity is ever-present in P. glacialis, regardless 
of the environmental changes, both abiotic and biotic, introduced during this study. Extracts of 
P. glacialis cultivated in the 300,000 L PBR was used for isolation of compounds with 
antibiofilm activity. The isolation was performed in several steps using preparative HPLC to 
remove all possible impurities, to finally end up with pure substances that could be analysed by 
NMR for structure elucidation (details on method in paper III). 
A total of 6 compounds were targeted for isolation, three of them were evaluated as pure enough 
for NMR analysis, and two of them were pure enough for structural elucidation. The 
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compounds isolated was a hydroxy fatty acid methyl ester; methyl 3-hydroxyoctadecanoate 
(Figure 12) and a pheophorbide-like compound, both of which have previously been described 
[204, 205]. The antibiofilm assay revealed that both compounds showed some degree of 
inhibition of biofilm formation by S. epidermidis compared to the control. A study by 
Ingebrigtsen et. al (unpublished manuscript) [206] and a study by Lauritano et al. [125] reported 
antibiofilm activity in the diatom species Bacteriosira bathyomhala, Cylindrotheca Closterium, 
Thalassiosira antarctica var. borealis and Leptocylindrus danicus. This activity was observed 
in more complex fractions and not from isolated compounds. Antibacterial activity has 
previously been found in free fatty acids and EPA isolated from diatoms [47, 48]. Diatoms are 
known to have a high content of fatty acids, which can be a possible explanation for the previous 
found activity in extracts of several diatom species. Regarding the pheophorbide-like 
compound, such break-down products of chlorophyll are known to have diverse and somewhat 
unspecific bioactivities such as antiviral, antiinflammatory and cytotoxic activities, but 
antibiofilm activity has not previously been reported [206-208].  
Bacterial biofilms can grow on virtually any surface, and are known to cause an array of issues 
ranging from hospital acquired infections [209-211] to marine biofouling on ship hulls [212]. 
The biofilm is a polymeric matrix made up of proteins and polysaccharides wherein the bacteria 
are embedded. The matrix traps nutrients and water, and facilitates interspecies communication 
and horizontal gene transfer. At the same time, it protects the bacteria by suppressing the 
antibiotic penetration, making the biofilm highly persistent to treatment [213-215]. Biofouling 
can also cause significant problems in PBRs [216]. Microalgae and bacteria adhering to the 
walls of the PBR reduce the solar radiation in the culture and increase the release of DOC from 
the biofilm which is a substrate for bacterial growth. This makes the cultivation conditions 
unfavourable, leading to culture crashes which results in loss in yield, need for maintenance 
and lost income [179, 216]. This in most problematic in glass tubular or flat panel reactors 
which rely heavily on irradiation from the outside of the reactor. The PBRs used in this study 
were designed so that light sources could be submerged into the culture. Thus, biofouling could 
Figure 12: Structure of methyl 3-hydroxyoctadecanoate obtained by HMBC (arrow) and COSY (bold) NMR. 
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cause growth on the lights and other submerged equipment (sensors). In addition, the polymeric 
matrix could be a nutrient base for possible harmful bacteria causing harm. Production of 
antibiofilm and antibacterial compounds can therefore be a great advantage for a species used 
in mass cultivation. Our observation and experience with large-scale cultivation of P. glacialis 
has shown a surprisingly low formation of visible biofilm inside the PBRs. It has been quite 
remarkable that after several months of continuous cultivation, there were almost no growth on 
the walls of the PBR. Whether the lack of visible biofilm on the inside of the PBR is due to P. 
glacialis antibiofilm activity that we have found in the lab is not known at this stage. 
Regardless, we see it as a highly desired quality in species to be considered for mass cultivation.  
In terms of further investigation and possible commercialization of the antibiofilm agent(s), it 
is definitely a key point that the activity is present in P. glacialis at different cultivation 
conditions. Limited supply of material can sometimes be a prominent problem as secondary 
metabolites are often present in the organism in miniscule concentrations, a phenomenon 
known as the ‘supply issue’ [217]. An advantage with mass cultivation of microalgae is the 
potential to eliminate this supply issue. Earlier biodiscovery studies conducted on diatoms at 
Marbio, UiT have shown that cultivation of diatoms in laboratory scale (100 – 600 L) has 
yielded just enough biomass to run a limited selection of bioassays. The opportunity to run 
large-scale cultivation give us access to larger quantities of biomass. Large-scale cultivation 
facilitates bioactivity testing and chemical analysis without the worry that our extracts would 
not suffice. Our results combined with a renewable and sustainable production of P. glacialis, 
lays a proper foundation for further work towards commercialization of the biomass.  
5.5 Future perspectives  
When searching through literature on diatoms secondary metabolites, it is evident that they 
produce compound which are excreted into the environment [203]. As this study focused on 
compounds extracted from the collected biomass, it would be interesting to do a deeper 
investigation of what is present in the cultivation media. The exudates are highly interesting in 
terms of the antibiofilm activity found in this study. Experience with cultivation of P. glacialis 
has shown us that, contrary to many other microalgae used in large-scale cultivation, the 
cultures are not prone to growth of biofilm in the PBRs. This might be due to the discovered 
antibiofilm activity in the biomass, but it could also be due to possible exudates. Such a study 
could be performed both by absorbing compounds from the media using e.g. resin and by 
submerging a wide range of materials in the diatom culture to investigate biofilm formation. 
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This, in addition to a further investigation of other potentially bioactive compounds would lay 
a great foundation for possible commercial applications.  
Morphology is an aspect not included in the studies presented in this thesis. It has been 
mentioned that copepod exudates, copepodamides, influence diatom morphology. The chain 
length of Skeletonema marinoi have shown to decrease when exposed to copepodamides. Other 
studies have shown that both certain strains of bacteria, and temperature can affect the 
morphology of diatoms [218, 219]. A morphology study of P. glacialis in response to co-
cultivation with zooplankton or other changing environmental factors would be valuable. 
The OSMAC method was used as a tool to investigate whether it is possible to tigger production 
of bioactive metabolites in P. glacialis. Based on the results found, revealing elevated toxicity 
against human cell lines when co-cultivated with zooplankton, it would be tempting to 
investigate this further. It would be interesting to repeat the study, using other species of 
zooplankton, as well as higher concentrations of grazers to investigate the mechanism behind 
the increased toxicity. The use of OSMAC in diatom cultivation is something that should be 
explored further to uncover more information on the chemical ecology of diatoms and their 
potential for commercial mass cultivation and application.  
The future of commercial production of diatoms in CCU seems bright. A large-scale cultivation 
for sustainable production of marine ingredients for the Norwegian aquaculture industry is 
definitely a step in the right direction in terms of reaching the UN sustainability goals (Figure 
13). By cultivation of marine phytoplankton for fish feed arable land can be freed and the 
pressure on wild fish stocks could be reduced. Production of marine lipids and proteins the 
omega-3 content in salmon could be increased and the overall sustainability of farmed fish 
would be improved. The infrastructure used in the CCU project can be implemented and used 
at other point sources for CO2 emissions resulting in innovations and new technologies leaving 
behind a lower carbon footprint.  
 
 43 
6 Concluding remarks 
For large-scale production of marine diatoms with the aim of CO2 sequestration from point 
sources, it has been fundamental to investigate how the diatoms responds to large-scale 
cultivation conditions. The presented study aimed to uncover bioactivity related to extracts of 
P. glacialis and at the same time investigate how the species responded to environmental 
changes in terms of bioactivity and metabolic expression. Both bioactivity and cytotoxicity 
were found in the cultivation studies. Although, it was discovered that the direct addition of 
factory smoke does not elevate the cytotoxicity, and at the same time the beneficial antibacterial 
and antibiofilm activity is preserved. These results are very positive for the future of diatom 
CCU for production of marine food or feed ingredients. The OSMAC study revealed that the 
cytotoxicity of P. glacialis towards human cell lines increased when co-cultivated with 
zooplankton. These results are interesting and shows that OSMAC could be useful tool in the 
future to uncover interesting bioactive compounds. Furthermore, the antibiofilm activity was 
studied in depth and we managed to isolate compounds most likely to be responsible for the 
activity. This was the first evidence of antibiofilm activity in P. glacialis. Antibiofilm 
compounds in diatoms used in large-scale cultivation is highly beneficial as it can prevent 
biofilm formation and fouling in the PBRs decreasing the amount of maintenance needed.  
Figure 13: UN sustainability goals connected to the CCU project.  
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Large-scale production of marine diatoms demands an in-depth knowledge on chemical 
ecology of the cultivated species. The results found during this study have shown us that P. 
glacialis is a robust species with many good qualities that make it a good candidate for 
biological CCU and production of valuable marine biomass. The antibiofilm activity found 
opens up for further research in this area and antibiofilm compounds can be important for 
treatment of infections and prevent formation on medical devices. In addition, it can be valuable 
for treatment of biofilm in large-scale microalgae cultivation. The cultivation studies conducted 
during the work with this thesis has provided a new insight into the biochemistry of how 
diatoms respond to large-scale cultivation and environmental changes, though there is still a lot 
to uncover.  
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Abstract
Using industrial emissions as a strategy for CO2 sequestration
through carbon capture and utilization (CCU) in cultivation of
microalgae can potentially change cultivation factors such as
pH, nutrient availability and presence of trace metals, which
could alter the growth and metabolism of the microalgae. It is
therefore important to investigate whether such changes in
culturing conditions can lead to changes in the diatoms me-
tabolism, such as production of unwanted toxic compounds or
by reduction of the diatoms’ natural ability to control the
growth of competing microorganisms (e.g., by decreasing the
production of antibacterial compounds). The cold-water marine
diatom Porosira glacialis was cultivated in two, 6,000-L photo-
bioreactors in an industrial setting; one culture had the direct
addition of factory smoke, and to the other fresh air was added.
The biomass was extracted and screened for toxicity in viability
assays against human cells (cancer and normal lung fibroblasts)
and development of sea urchin larvae (Paracentrotus lividus).
Bioactivity was tested in two bacterial assays: growth inhibition
assay and anti-biofilm assay. The results confirm earlier reports
on the presence of toxic compounds against human cell lines and
P. lividus larvae, but no elevated toxicity could be detected using
factory smoke. Anti-biofilm activity was present in both cultures.
This indicates that the natural toxic properties of the microalgae
do not increase by adding factory smoke, and that we keep the
beneficial ability of the microalga to suppress growth of bacteria.
These are key elements in a successful, industrial-scale cultiva-
tion as the product is safe and at the same time the monocultures
are not being contaminated by competing organisms.




arine diatoms are of great importance as primary
producers in highly productive temperate and
Arctic ocean areas, as well as in southern up-
wellings.1–3 Diatom biomass contains an array of
valuable nutrients and bioactive compounds with commercial
potential, including marine long chained polyunsaturated fatty
acids such as eicosapentaenoic acid (EPA) and docosahexaenoic
acid (DHA);4,5 amino acids and ß-carotene with cosmetic ap-
plications;6,7 carotenoids with applications in food/feed industry
and as pharmaceuticals;8,9 oil with potential for biofuel pro-
duction;10,11 and as feed ingredients in aquaculture.6 In addition,
typically for microorganisms, diatoms have high growth rates
(they double by binary fission), making them promising candi-
dates for mass cultivation and production of valuable marine
biomass.12 Despite this, the global production volume of culti-
vated microalgae is small, i.e., less than 20,000 tons.13 This is
due to technological limitations with respect to scalability and
economic sustainability of the currently available cultivation
technology.14 The photobioreactor types used today are quite
diverse, ranging from small-scale closed tubes to large open
ponds.15,16 Many systems are complex constructions and prone
to growth of unwanted bacterial or algal biofilms on the surfaces
of the bioreactors.17 Development of economically viable cul-
tivation systems with stable and optimal biological environ-
ments are therefore important if mass production of microalgae
shall develop further.
Mass cultivation of microalgae at high densities requires ad-
dition of CO2 at concentrations higher than what is naturally
present in air and sea. One ‘‘low-cost’’ way to overcome this
issue is to boost production by injecting factory smoke with el-
evated CO2 concentrations to the cultures.
18 Fossil CO2 emissions
is one of the factors contributing to climate change, and reduc-
tions in CO2 emissions is regarded as one of the main approaches
to reduce these problems. Several CO2-mitigation strategies have
been evaluated over the years, such as carbon capture and storage
(CCS), e.g., aiming to store CO2 in geological reservoirs;
19 or
carbon capture and utilization (CCU).20 Diatoms are promising
candidates for biological CCU because of their high growth rates
and hence their ability to fixate large amounts of CO2 through
photosynthesis.14,18,21 Since diatom biomass contains valuable
marine long chained polyunsaturated fatty acids such as EPA and
DHA,4,5 it can therefore be considered a potential sustainable
source for feed ingredients for the aquaculture industry.14,22 This
facilitates production of valuable commercial products coupled
to reduced emissions of greenhouse gases through CCU.

















































Cultivation of photosynthetic microalgae has been practiced
for more than 100 years, and the use of microalgae to capture
CO2, also from factory smoke, has been investigated over recent
decades.23 Industrial activities might have a negative impact on
human health and the surrounding environment through emis-
sions of factory smoke and dust-containing climate gases and
pollutants such as heavy metals. If CCU through the production
of diatom biomass is to become a successful industrial process, it
is important to investigate possible metabolic changes in the
microalgae triggered by industrial smoke that might affect the
quality of the product.
Diatoms produce an array of low molecular weight secondary
metabolites, some of which are known to deter grazing zoo-
plankton and other organisms competing in the same ecological
niche.24–28 These secondary metabolites have developed as
mechanisms to cope with the constant pressure of grazers,
bacteria and viruses that can be found in their aquatic habitats.29
Oxylipins, especially polyunsaturated aldehydes (PUAs), have
been studied due to their teratogenic effect against echinoderms
and copepods.30–33
Previous studies have shown that, when grown under different
and often extreme conditions with respect to temperature,34 il-
lumination,35 and growth media,36 marine diatoms may alter
they biochemistry, leading to changes in growth rates, bioac-
tivity and toxicity. Use of CO2 directly from factory smoke
changes the cultivation conditions, and it is important to in-
vestigate whether the this could lead to an increase in production
of toxic compounds or alter the production of beneficial bio-
active compounds naturally present.
The study was designed to investigate whether the direct use
of factory smoke in the cultivation process could trigger
changes in diatom biochemistry and bioactivity. A set of via-
bility assays was chosen to screen for toxicity. Viability assay
were carried out for three human cells lines (human colon
carcinoma, human melanoma and normal lung fibroblasts) and
development of echinoderm larvae (Paracentrotus lividus).
The bioactivity assessment of the biomass was done using a
bacterial growth inhibition assay against
Staphylococcus aureus, Escherichia coli,
Enterococcus faecalis, Pseudomonas aer-
uginosa and Streptococcus agalactiae, and
anti-biofilm assays agianst biofilm forma-




A stock culture of P. glacialis was started
from cells collected near the ice edge
southeast of Spitzbergen during a research
cruise with the Norwegian research vessel
Helmer Hanssen in spring 2014. Isolation
was done under a microscope (Primo Vert,
Zeiss, Oberkochen, Germany) using a
manual capillary pipette, and single cells
were transferred to a 24-well plate (Nunc)
with autoclaved seawater. Taxonomical
identification was done based on morphological and genetic
characters.37,38 Non-axenic monocultures of this diatom have
since been maintained in culture in Guillard’s f/10 marine water
enrichment solution (Sigma-Aldrich), at the Norwegian College
of Fishery Science in Tromsø, Norway.
Cultivation of P. glacialis was done at an industrial test cul-
tivation facility in Northern Norway. The cultivation is aimed at
utilizing factory smoke CO2 (factory smoke composition can be
found in Supplementary Table S1) in photosynthesis to produce
nutritious marine biomass to be applied as e.g., food and
aquaculture feed, i.e., CCU.
Cultivation was performed in parallel in two open 6,000-L
vertical column photobioreactors, and an overview of the cul-
tivation process is presented in Fig. 1. Both reactors were cy-
lindrical with a diameter of 1.7 m and height of 2.5 m. One was
made of steel and the other of fiberglass (the difference in
material did not affect the growth of the diatoms). Seawater was
pumped from 25 m depth and filtered through a series of 4 filters
with 1 lm pore size (Pall Water, New York, NY, USA) and
germicidal UV-lamps (Nordisk Vannteknik, Stockholm,
Sweden). Inorganic plant nutrients, i.e., SubstralTM (Scotts
Company, Nordics A/S, Glostruk, Denmark) was added to a
concentration of 0.25 mL L-1 (substral content found in Sup-
plementary Table 2). Silicate solution prepared from Na2O3-
Si · 9H20 (Sigma-Aldrich, St. Louis, MO, USA) was added to a
concentration of 12.3 lmol L-1. Artificial daylight white LED-
illumination submerged in the culture was used as illumination
in both cultures (mean intensity ca. 45 lmol photons m-2 s-1 in
the middle of the reactor) at 24 h photoperiod. Factory smoke
was added daily in intervals (2–4 hr) throughout the culivation
period. The addition of factory smoke was controlled by pH
measurements as the pH value decreases with the increase of
dissolved CO2 in the sea water. The addtion of smoke was
stopped before the pH dropped below pH 6.5. pH was measured
manually using a handheld pH-meter (WTW MultiLineMulti
3630 IDS) and controlled every 15 min. The smoke was
added directly from the factory outlet pipes using a compressor
Fig. 1. Overview of cultivation experiment workflow. Color images are available online.
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(6 bar/ 201 L min-1) and dispersed into one of the cultures
through a system that facilitates mixing by bubbling from the
bottom of the reactor. Manually controlled valves were ad-
justed to accommodate an appropriate amount of bubbling that
would not damage the cells under excessive mechanical stress.
The same system was used in the second cultivation tank, but
with addition of pressurized air instead of factory smoke.
Both cultures were inspected daily to check for contamina-
tion and state of the cells (color, shape, chromatophore ar-
rangement) to make sure both cultures remained healthy.
Biomass concentration was monitored daily by counting of
cells in an inverted microscope39 and by measuring the con-
centration of the photosynthetic pigment chlorophyll a.
Chlorophyll a was measured using the method of Holm and
Riemann40 with ethanol (96%, Sigma Aldrich) as extractant and
quantified using a Turner Designs fluorometer (TD 700, Sun-
nyvale, CA, USA). Temperature and pH were monitored
throughout the cultivation period.
Cultures were harvested when the number of cells reached
between 5.2–5.9 million cells L-1 to avoid differences in cul-
tivation conditions due to cell concentrations. Desired con-
centration was reached after 4–6 days and 3,000 L of both
cultures were harvested using a continuous centrifuge (Algae
Centrifuge, Sacramento, CA, USA). After centrifugation, the
biomass was frozen and stored at -20C until further use. To
continue cultivation, 3,000 L of filtrated water was added to
both cultures, in addition to nutrients and silicate solution in
the same concentration, as stated earlier. Cultivation then
continued for 4–6 days before 3,000 L of each culture was
again harvested and stored at -20 C.
SAMPLE PREPARATION AND FLASH FRACTIONATION
Samples were freeze-dried (Heto PowerDry PL9000, Thermo
Fisher Scientific, Waltham, MA, USA), crushed and extracted
using a protocol developed for marine plants and animals.41 The
samples were first extracted overnight using Milli-Q H2O
(Millipore, Burlington, MA, USA) at 4C and subsequently
centrifuged (4,600 rpm). The supernatant was freeze-dried and
ground into a fine powder. The remaining pellet was freeze-
dried and re-extracted three times (3 x 4 h in room temperature)
with a 1:1 mixture of methanol and dichloromethane (vol:vol)
(Sigma Aldrich). The organic extract was evaporated under re-
duced pressure (Laborata 4002, Heidolph, Schwabach, Ger-
many). Dried aqueous and organic extracts were stored at -20C
until further use.
The extracts were Flash fractionated using a Biotage SP4
Flash chromatography system using self-packed Biotage col-
umns (Uppsala, Sweden) with 6.5 g of Diaion HP-20SS resin.
Approximately 1.5 g of the organic extract was resuspended in
hexane (40 mL g-1 sample). The hexane solution was transferred
to a separating funnel, a 90% aqueous MeOH (30 mL x 2) was
added, and the solution was mixed carefully. After separation,
the lower liquid phase (MeOH) was transferred to a round-
bottomed flask and 2 g of Diaion HP-20SS resin was added and
dried under reduced pressure. For the preparation of aqueous
extracts, 1.5 g were transferred to two 13-mm glass tubes, to
which was added 4 mL of 90% MeOH, 1.5 g of Diaion HP-20ss
resin and 1 mL of Milli-Q H2O, before the mixture was dried
under reduced pressure. Fractionation was done in two steps:
first with a gradient of 5–100% MeOH and MilliQ-H20 at a flow
rate of 12 mL min-1 over 32 min, and then a MeOH:acetone
gradient ending at 100% acetone, flow rate 12 mL min-1 over
18 min. The eluent was collected into 8 separate fractions and
dried under reduced pressure before dissolving in 100% DMSO
to a concentration of 40 mg mL-1.
BIOACTIVITY AND TOXICITY SCREENING
Viability assay human cells. All Flash fractions were tested
against two cancer cell lines: A2058 Human melanoma (LGC
Standards ATCC CRL-11147, Teddington, Middlesex, UK)
and HT29 Human colon carcinoma (LGC Standards ATCC
HTB-38), and against normal lung fibroblast MRC5 (LGC
Standards ATCC CCL-171). Assays were performed on 96-well
plates (Nunc, Roskilde, Denmark). 2,000 cells were seeded into
each well (4,000 cells per well for MRC5 cell line). Roswell
Park Memorial Institute 1640 cell medium with 10% fetal bo-
vine serum and 10 mg mL-1 gentamicin was used as a cell
growth medium, and the seeded plates were incubated at 37C
in 5% CO2 for 24 h. After the incubation period, the culture
medium was replaced (50 lL) and the cells were then exposed
to the Flash fractions (50 lL) giving a total volume of 100 lL in
each well. All fractions were tested in triplicate. Culture me-
dium and Triton X-100 were used as a negative and positive
controls, respectively. Plates were then incubated for another
72 h, before adding 10 lL of CellTiter 96 Aqueous One So-
lution Reagent (Promega, Madison, WI, USA) and incubated
for another 1 h with the reagent. Absorbance was read using a
DTX 880 Multimode Detector at 485 nm, and results were
calculated as % cell survival compared to the aforementioned
positive and negative controls.
Sea urchin development assay. Toxicity assays on sea urchin
larvae were performed at the Observatoire Oceanologique in
Banuyls sur Mer, France. Mature Paracentrotus lividus (La-
marck, 1816) sea urchins were collected in the Mediterranean
Sea near Banyuls sur Mer. Spawning was induced by shaking
the sea urchins and thereafter placing them with the gonopore
facing down on top of a beaker with seawater. Sperm was re-
leased in long viscous threads that could be collected with a
pipette and transferred to a petri dish to be stored at high con-
centration. The egg suspension was filtered through a 120-lm
mesh nylon filter to get rid of feces and debris. The experiment
was performed in a temperature-controlled room at 18C. Eggs
were left to sediment and washed twice with filtered seawater
(0.22 lm, Millipore). The density of eggs was counted under a
microscope and diluted to 700 eggs mL-1. Sperm was diluted by
transferring 10 lL of concentrated sperm to 1 mL seawater and
from this dilution 1 lL per 1 mL was added to the solution of
eggs. One minute after fertilization, the eggs were checked for
the presence of a fertilization membrane. The assay was per-
formed in 24-well plates (Nunc) and 1 mL of fertilized eggs
were transferred to a prepared plate with extracts. All extracts
were tested in duplicates. Plates were controlled after 2 h for
inhibition of first cell division and left at 18C for development.
OSVIK ET AL.

















































Pictures of each well were taken 24, 48 and 72 h after fertil-
ization. Pictures were taken of sub-samples of each well fixated
with 4% formaldehyde. Analysis of results was done based on
visual examination of larvae in living samples, and the pictures
taken after 48h.
Bacterial growth inhibition assay. All flash fractions were tes-
ted for antimicrobial activity in a growth inhibition assays
against 5 bacterial strains: Staphylococcus aureus (ATCC
25923), Escherichia coli (ATCC 25922), Enterococcus faecalis
(ATCC 29212), Pseudomonas aeruginosa (ATCC 27853), and
Streptococcus agalactiae (ATCC 12386). Colonies of each
bacterial strain were transferred from blood agar plates and in-
oculated for at 37C for 24 h in 8 mL growth media; S. aureus,
E. coli and P. aeruginosa in Mueller-Hinton media (MH, Becton
Dickinson, Franklin Lakes, NJ, USA) and E. faecalis and
S. agalactiae in brain heart infusion media (BHI, Sigma-
Aldrich). After 24 h, 2 mL was transferred to 25 mL of new
growth medium, incubated until log-phase was reached, and
diluted 1:1,000 to adjust the density. The bacterial solution was
then transferred to 96-well microtiter plates, 50 lL in each well,
and the fractions were added to the plate to a total volume of
100 lL per well. All fractions were tested in duplicates. Plates
were then incubated at 37C overnight, and growth was mea-
sured, first by visual examination, and then absorbance at
600 nm was measured in a VICTOR 1420 Multilabel Counter
(Perkin Elmer, Waltham, MA, USA).
Inhibition of biofilm formation. The biofilm-forming bacterial
strain Staphylococcus epidermidis (ATCC – 35984) was used in
this assay. Colonies of S. epidermidis were seeded from blood
agar plates in Tryptic Soy Broth enrichment media (TBS,
Merck, Burlington, MA, USA) and incubated overnight at 37C,
before being diluted 1:100 in TBS with 1% glucose. The assay
was performed in 96-well plates, and 50 lL bacterial suspension
was transferred to each well, while 50 lL of fractions were ad-
ded in triplicates. The non-biofilm producing strain Staphylo-
coccus haemolyticus (Clinical isolate 8-7A) was used as a
negative control, to which was added a 50-lL bacterial sus-
pension and 50 lL dH2O. The blank control consisted of 50 lL
TBS and 50 lL dH2O. Plates were incubated overnight at 37C.
The bacterial suspension was then removed by carefully turning
the plates upside down and washing with MQ-H2O before the
biofilm was fixated at 55C for 1 h. A solution of 0.1% crystal
violet was then added to each well for 5 min and removed by
washing the plates twice with MilliQ-H2O. The plates were
thereafter dried at 55C and visually examined for the formation
of biofilm and then resuspended in 70 lL EtOH before reading
the absorbance in a VICTOR 1420 Multilabel Counter (Perkin
Elmer) at 600nm.
Removal of established biofilm. S. epidermidis was grown
overnight in TBS at 37C and diluted 1:100 in TBS with 1%
glucose. The bacterial culture (50 lL) and dH2O (50 lL) was
then transferred to a 96-well plate. S. haemolyticus was used as a
negative control, and TBS (1% glucose) and dH2O (1:1) as the
blank. Plates were incubated at 37C for 24 h. Enrichment media
was removed by gently turning the plate upside down, and the
plates were washed 2 x with PBS. Fresh TBS (1% glucose) was
added in addition to the fractions (50 lL) in triplicates; prior to
that the plates were incubated for 24 h at 37C. Fixation, col-
oring and reading of absorbance was done following the same
method as in the inhibition of biofilm formation assay.
STATISTICAL ANALYSIS
Statistical differences of samples cultivated with and without
factory smoke for the viability assays were determined by Stu-
dent’s t-test using the program Prism 7 for Mac OS X V7.0e
(GraphPad Software Inc.). Data were considered significant
when at least p was <0.05. All figures were made using the same
software.
Results and Discussion
Mass cultivation of marine microalgae using industrial fac-
tory smoke as a source of CO2 can be a sustainable and feasible
way to produce nutritious biomass to be applied as food and/or
feed. However, a relevant question is if the use of factory smoke
changes the metabolism of the diatoms and could trigger them to
produce previously unknown toxic substances that can be del-
eterious to marine organisms and humans. The present study
was therefore designed to enable investigation of possible
changes in biological effects of the extracts of P. glacialis after
exposure to factory smoke. As it is known that certain growth
conditions such as temperature, light and nutrient availability
can affect the biochemistry of diatoms, it was important to keep
all growth conditions as similar as possible, except for the ad-
dition of factory smoke.
Cell counts showed an overall increase in biomass from the
first day until the day of harvest, with growth rates between
0.11–0.21 doublings day-1 in the four cultures (Fig. 2a). The
high number of cells in culture NS2 on day two is most likely
due to an error in counting,42 since the chl a value (Fig. 2b)
showed a concentration corresponding to a lower cell density.
P. glacialis is a large diatom (25–50 lm diameter), and the cell
densities were equivalent to 0.1–0.15 g L-1 biomass when har-
vested. Addition of CO2 is used to enhance growth rates and
densities in mass cultivation, but in the present experiments
optimization of cultivation conditions was not a priority. The
effect of added CO2 on growth rates is usually observed at higher
cell densities when the atmospheric and ocean concentration of
CO2 becomes a growth-limiting factor. We did observe that the
growth of P. glacialis was not affected negatively by the factory
smoke added directly to the culture.
Parameters such as pH and temperature were closely moni-
tored (Fig. 3). During the first cultivation (NS1 and S1), the
temperature ranged from -0.2 to 3.6C, while during the second
cultivation period (NS2 and S2), the temperature ranged from
2.2 to 3.8C (Fig. 3a). The variation in temperature was due to
the outdoor location of the cultivation facility, i.e., the air and
sea water temperatures had an impact on the cultivation tem-
perature. Note that cultures grown in parallel had similar tem-
peratures throughout the period. P. glacialis is a northern
temperate/Arctic species with a wide, but not much varying
temperature range, with maximum growth at ca. 12C and still
EFFECT OF FACTORY SMOKE CO2 ON DIATOM BIOACTIVITY

















































positive growth even at sub-zero water temperatures. In a study
by Svenning et al.,5 a growth rate of 0.17 doublings day-1 was
logged at -2C and 0.41 at 12C in 100-L Plexiglas columns,
while results from the temperature range between 2 and 12C
were not statistically different. Gilstad and Sakshaug43 observed
a maximum growth rate at light saturation of 0.2 to 0.4 doublings
day-1 in small-scale experiments (20 mL) at temperatures
around 0C. Hence the growth rates measured in the present
study were in the same range as the two aforementioned studies,
and the observed discrepancies could possibly be explained by
differences in reactor size, even if all experiments reported the
same (low) light saturation (50–75 mmol photons m-2 s-1) and
no inorganic nutrient scarcity.
Daily pH measurements (Fig. 3b) were made, once a day in
cultures NS1 and NS2 and twice a day in cultures S1 and S2
(before and after addition of factory smoke). Cultures without
addition of smoke had a stable pH ranging from 8.03–8.23
throughout the cultivation periods. Fluctuations in the pH values
in culture S1 and S2 were due to the addition of factory smoke
containing CO2, which dissolves in the seawater and lowers the
pH; the average values before and after the addition of smoke
were 7.95 and 7.28 respectively.
BIOACTIVITY AND TOXICITY ASSAYS
The aqueous and organic crude extracts were each fraction-
ated into eight fractions using Flash chromatography to reduce
the chemical complexity of the extracts. The biological char-
acterization of the extracts was done by testing all fractions in a
selection of toxicity and bioactivity assays: viability of human
cancer cells and normal lung fibroblasts; an in vivo sea urchin
development assay and two bacterial assays; a growth inhibition
assay; and an anti-biofilm assay. In all assays, only results from
organic fractions are shown, as there was no activity to report
from the aqueous fractions.
Viability assay. Cell viability assays were performed on three
different cell lines (Fig. 4): human melanoma, human colon
carcinoma, and normal lung fibroblasts. All the organic fractions,
Fig. 2. Cell numbers in (a) cells L-1 and (b) chlorophyll a concentration (lg L-1) vs. time for the four diatom cultures of P. glacialis; two
cultures grown without factory smoke (NS1 and NS2), and two cultures grown with factory smoke (S1 and S2). Chl a represents values of
three replicates.
Fig. 3. (a) Temperature (C) and (b) pH measurements of samples NS1, NS2, S1 and S2 during cultivation of P. glacialis. Daily measurement
was taken in cultures NS1 and NS2. pH in cultures S1 and S2 were measured twice each day, before and after addition of factory smoke.
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64 in total, were tested at 100 lg mL-1. Figure 4 shows the
toxicity profiles of all four samples (i.e., NS1, NS2, S1 and S2).
Toxicity screening of the diatom fractions showed that there
were anti-proliferative effects against the two human cancer cell
lines human melanoma (A2058) and human colon carcinoma
(HT29), and all activity was found in fractions 3, 4, and 5. Ac-
tivity profiles showed a few differences between the treatments;
fraction 3 in NS2 and fraction 4 of S1 were not active against
human colon carcinoma (Fig. 4b), and only fraction 5 of samples
cultivated without smoke (NS1 and NS2) were active against
human melanoma (Fig. 4a). For the remaining fractions, the
activity seems to be similar for the two cultivation treatments,
without any clear differences. Statistical analysis of results from
the bioassays with the two cancer cell lines revealed no statisti-
cal significance between the two treatments (Student’s t-test
p > 0.05). An assay was also performed on normal lung fibro-
blasts (MRC5) to assess toxicity against normal human cells.
The assay indicated no reduction in cell survival for any of the
tested fractions from all four samples (Fig. 4c). The results in-
dicate that there was no toxicity in the extracts against normal
human lung fibroblasts, and no differences between the two
cultivation treatments, showing that direct addition of factory
smoke during the cultivation of P. glacialis did not lead to any
elevated toxicity in the extracted biomass.
Anti-cancer activity has been reported in extracts of several
marine diatom species.28,44–46 Sansone et al.47 found that
diatom-derived PUAs had activity against two cancer cell lines
but no activity against normal human cell lines. Studies on
bioactivity in P. glacialis are scarce, with less than a handful of
publications on this species.35,48 A study of bioactivity in cold
water diatoms, including P. glacialis, was done in our research
group by Ingebrigtsen et al.,35 which found anti-cancer activity
against human melanoma cells. The present study confirms
these results and show that the activity was still present when
P. glacialis was cultivated in large scale. We also found that
large-scale cultivation using factory smoke does not directly
trigger any increase in toxicity against human cell lines.
Sea urchin development assay. A sea urchin development assay
was conducted to assess the impact of the extracts on larvae of
Paracentrotus lividus. The results revealed that the organic ex-
tracts of P. glacialis had toxic effects against P. lividus larvae.
The toxicity assay was carried out in two stages. First, flash
fractions were screened at a concentration of 100 lg mL-1 to
investigate which fractions were active or not, followed by a
dose-response assay of the three most active fractions. The re-
sults from the initial assay of the organic flash fractions from
NS1 after 48 h are shown in the micrographs in Fig. 5. The
toxicity of the fractions of all four samples were similar, there-
fore the results from fraction 1–8 of NS1 (Fig. 5) are represen-
tative for all four samples (NS1/2 and S1/2). When referring to
the fractions, the same results apply to all four samples. In
fractions 1 and 8, the larvae were fully developed except for a
few minor abnormalities, similar to the controls, and were
therefore not regarded as active. Larvae treated with fraction 2
and 3 reached the pluteus stage of development, but with de-
formations, showing that there was some toxicity in these frac-
tions, but not high enough to regard the fractions as active.
Fraction 4 of the organic extracts inhibited the initial cell division
at 100 lg mL-1, and fraction 5–7 arrested cell division before
reaching early blastula, after approximately 10 cell divisions.
Fractions 4–7 had a clear toxic effect on the sea urchin larvae.
Based on the results of the initial screening, a dose-response
assay was performed with the concentrations 100, 75, 50, 25 and
5 lg mL-1 on fraction 4, 5 and 6 from all four samples.
The activity profile for fractions 4, 5 and 6 from all four
samples tested can be seen in Fig. 6, showing the percentage of
Fig. 4. Activity profiles of all fractions in samples NS1 (blue), NS2
(green), S1(yellow) and S2 (red) tested at 100 lg ml-1 against
(a) A2058 human melanoma, (b) HT29 human colon carcinoma
and (c) MRC5 normal lung fibroblasts. Fractions with cell viability
lower than 50% is considered active. Data represents mean of
3 replicates. Color images are available online.
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normally developed sea urchin larvae for each of the treatment
concentrations. There were no normal development in treat-
ments at 50 lg mL-1 and above. Treatments at 25 lg mL-1 also
showed severe effects on the sea urchin larvae that experienced
no normal development. At 5 lg mL-1, the survival was 35–
55%, while the control had 60% survival. The overall activity of
all the samples and fractions were almost identical when com-
paring the two cultivation treatments. This shows that the in-
dustrial smoke used in the cultivation neither increased nor
decreased the toxicity against P. lividus larvae, and that the
compound(s) responsible for the effect was present in both
cultures (NS1 + 2 and S1 + 2).
Effects of diatom extracts on echinoderms and copepods
have been well-studied through several experiments where
they have shown teratogenic effects,32,49–52 and PUAs have
been shown to be the one of the culprits.52,53 A previous study
by Gudimova et al.54 where both fertilized eggs and larvae
(4- and 6-armed development stages) of the sea urchin Para-
centrotus droebachiensis were exposed to living cells of
P. glacialis showed that the living diatoms had an anti-
proliferative activity on the fertilized eggs, and that the larvae
avoided grazing on the diatoms. No previous studies on the
effect of extracts from P. glacialis have been found, making
this the first one to document its effect on P. lividus larvae
development.
Antibacterial growth inhibition assay. Open photobioreactors
for mass cultivation of marine algae are challenging, if not
impossible, to keep free of bacterial contamination. Whereas
several bacterial strains are important symbionts to the diatoms,
some bacteria can cause problems and lead to a decrease in
growth and fitness of the algae.29,55,56 Several diatom species
have shown antibacterial effect,29 and the diatoms natural ability
to prevent bacterial growth is important to consider in a mass-
cultivation scenario. To test the antibacterial effect of P. gla-
cialis, the extracted biomass was tested against a selection of
bacterial strains, both Gram-negative (E. coli and P. aeruginosa)
and Gram-positive (S. aureus, E. faecalis and S. agalactiae). All
fractions were tested at a concentration of 100 lg mL-1 and a
fraction was regarded as active against the bacteria when ab-
sorbance at 600 nm was <0.05.
Results of the assay revealed that fractions from all samples
had activity against the Gram-positive bacteria S. agalactiae.
All four samples showed similar activity, where fractions 4 and
5 were active, except in sample S2 where only fraction 4 was
active. As there was no clear difference in activity between the
two cultivation treatments, it seemed as though cultivation with
factory smoke had no effect on the antibacterial activity of P.
glacialis. Anti-bacterial effects of diatoms in general are poorly
documented, and there is only one study on P. glacialis per-
formed by Ingebrigtsen et al.,35 and no activity was found there.
The results show that P. glacialis had anti-bacterial effect
against S. agalactiae.
Inhibition of biofilm formation. The formation of bacterial
biofilm, and subsequent build-up of fouling by algae, is one of
the issues in mass cultivation of diatoms and other micro-
algae.17 Bioactivity that inhibits formation of bacterial bio-
films could therefore be a useful trait in diatoms for mass
cultivation. P. glacialis showed activity against formation of
biofilm by S. epidermidis. This bacteria is considered a com-
mon cause of hospital infections,57,58 and is a sensitive assay
when screening for compounds that can inhibit biofilm forma-
tion. The screening was done at a concentration of 100 lg mL-1,
and the results are shown in Fig. 7. Fractions were regarded as
active when absorption was <0.25 at 600 nm. As can be seen
from Fig. 7, there is little that separates the two sample sets from
each other in terms of activity. Fraction 3 of all four samples
were active, and except for NS2, fraction 4 is active in the re-
maining three samples.
These results show that, just like in the growth inhibition
assay, factory smoke seems to have no apparent effect on the
biofilm activity of the extracted biomass. What is interesting
with these results is the anti-biofilm activity itself; only a few
studies have been conducted on anti-biofilm activity in diatoms,
except for research on biofilm formed by the diatoms
Fig. 6. Activity profiles from sea urchin toxicity assay of fraction 4, 5 and 6 in sample NS1, NS2, S1 and S2. Activity is measured in % normal
developed larvae after 48 h of exposure to fractions at 100, 75, 50, 25 and 5 lg mL-1. All malformed and dead larvae are counted as not
normal. Data represents mean of two replicates.
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themselves, usually by pennate diatoms.59,60 The study by
Lauritano et al.36 showed anti-biofilm activity in the diatoms
Leptocylindrus danicus and Leptocylindrus aporus against
biofilm formation by S. epidermidis. The present study is the
first to report anti-biofilm activity in extracts from a marine
cold-water centric diatom. Activity against biofilm formation
can be promising, in particular for combating hospital infections
related to medical devices, but also for the development of novel
anti-fouling compounds for marine industries. During the
P. glacialis cultivation period of two weeks, there was no for-
mation of visible biofilms on the walls of the bioreactor or on the
equipment that were continuously submerged in the diatom
cultures. Biofilm formation of bacteria in sea water can establish
quite fast—about one week on plastic61—and it is likely that the
same applies to fiberglass and metal bioreactors like those used
in this study. Earlier experiments (not published) in the same
bioreactors showed no formation of biofilm after a period of four
months. The absence of biofilms is promising for the prospects
of mass cultivation of microalgae. Growth on the surfaces of
bioreactors leads to reduction of light efficiency in tube or plate
reactors, higher maintenance costs as the tanks and equipment
need frequent cleaning, and lowered quality of culture condi-
tions due to accumulation of bacteria in the biofilm.17 The anti-
biofilm activity combined with the observed absence of growth
on reactor walls suggests that there are active anti-biofilm
compounds produced by P. glacialis, and that the natural ability
to inhibit formation of bacterial biofilm is not changed by adding
factory smoke during cultivation.
The results indicate that the direct use of factory smoke as a
source for CO2 when mass cultivating P. glacialis, does not
change the positive biological effects of extracts of the bio-
mass, and does not lead to increased toxicity against neither
human cells nor sea urchin larvae. In addition, valuable bio-
activity such as inhibition of biofilm formation is preserved.
Anti-biofilm compounds in the biomass can have positive
effects in cultivation as it leads to less fouling of photo-
bioreactors and can be useful in the search for new anti-fouling
compounds.
Conclusion
Mass cultivation of marine diatoms demands amounts of CO2
above atmospheric concentrations. The direct use of factory
smoke as a source of CO2 could therefore be a possibility to ensure
sustainable production of biomass. Such cultivation of diatoms
would also be a means of decreasing CO2 emissions through
carbon capture and utilization. As the use of factory smoke CO2
changes the cultivation conditions, a thorough mapping of the
changes in the biological effects of the biomass is important to
ensure safe production, avoid deleterious effects of harmful
compounds, and comply with existing food/feed regulations.
The results of the present study confirm the well-known fact
that diatoms produce metabolites that may act toxic, but the
toxicity does not increase when factory smoke is added in
the cultivation process. It is therefore possible to mass cultivate
the marine diatom P. glacialis using factory smoke as a direct
source of CO2 without affecting and increasing the biomass
toxicity, and at the same time preserving valuable anti-bacterial
and anti-biofilm activity in the biomass. The research was based
on the biological effects observed through a set of bioassays, and
future chemical analysis should be performed to investigate the
biochemistry of the biomass to analyze possible changes and to
identify possible interesting compounds responsible for the anti-
biofilm activity.
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Abstract: “One strain many compounds” (OSMAC) based approaches have been widely used in
the search for bioactive compounds. Introducing stress factors like nutrient limitation, UV-light
or cocultivation with competing organisms has successfully been used in prokaryote cultivation.
It is known that diatom physiology is affected by changed cultivation conditions such as temper-
ature, nutrient concentration and light conditions. Cocultivation, though, is less explored. Hence,
we wanted to investigate whether grazing pressure can affect the metabolome of the marine diatom
Porosira glacialis, and if the stress reaction could be detected as changes in bioactivity. P. glacialis
cultures were mass cultivated in large volume bioreactor (6000 L), first as a monoculture and then as
a coculture with live zooplankton. Extracts of the diatom biomass were screened in a selection of
bioactivity assays: inhibition of biofilm formation, antibacterial and cell viability assay on human
cells. Bioactivity was found in all bioassays performed. The viability assay towards normal lung
fibroblasts revealed that P. glacialis had higher bioactivity when cocultivated with zooplankton than
in monoculture. Cocultivation with diatoms had no noticeable effect on the activity against biofilm
formation or bacterial growth. The metabolic profiles were analyzed showing the differences in
diatom metabolomes between the two culture conditions. The experiment demonstrates that grazing
stress affects the biochemistry of P. glacialis and thus represents a potential tool in the OSMAC toolkit.
Keywords: diatoms; microalgae; biotechnology; biodiscovery; OSMAC; cultivation
1. Introduction
The number of investigations of bioactive compounds from marine microorganisms
has increased over the last few decades [1]. This is a natural development, since access
and expeditions to the various parts of the water that covers 70% of the earth’s surface
have increased during the recent years. These diverse aquatic biotopes are inhabited
by millions of species of microorganisms, both prokaryotic and eukaryotic. Using high
throughput DNA sequencing, it has been found that there are a number of biosynthetic
gene clusters (BGCs) that are linked to the production of secondary metabolites. These are
not necessarily expressed when the microorganisms are cultured under laboratory condi-
tions [2]. This realization eventually led to a concept termed “one strain many compounds”
(OSMAC) [3], stating that many microorganisms have the potential to produce a broad
range of secondary metabolites, but that only a few are synthesized under specific growth
conditions. It is therefore possible to alter growth conditions such as nutrient concentration,
Mar. Drugs 2021, 19, 87. https://doi.org/10.3390/md19020087 https://www.mdpi.com/journal/marinedrugs
Mar. Drugs 2021, 19, 87 2 of 17
physical conditions, trace elements and the presence of other species through cocultiva-
tion to induce the production of a wider range of secondary metabolites. The OSMAC
approach has led to the discovery of novel bioactive compounds. Uchoa et al. found
that a strain of Aspergillus niger produced a novel furan ester derivative with bioactivity
against a colon carcinoma cell line (HCT-116), when cultivated in MPDB (malt peptide
dextrose broth medium) [4]. Cocultivation of two Aspergillus sp. strains and the marine
fungi Avicennia marina led to the isolation of a new alkaloid with antibacterial activity
against E. coli [5]. These examples and several others show us that OSMAC has become an
important tool in the field of natural product biodiscovery [2,5–9].
One of the most diverse groups of marine microorganisms are the diatoms [10,11],
which are a largely unexplored source of chemical diversity. Most OSMAC cultivation
experiments have involved prokaryotes, and there are only a few studies involving marine
microalgae. A study by Lauritano et al. [12] showed that nitrogen concentration influenced
anticancer and antibacterial properties of the diatom Skeletonema marinoi. A study by
Ingebrigtsen et al. [13] demonstrated that the bioactivity of five diatom species changed
with different light and temperature regimes, e.g., S. marinoi only showed anticancer
activity when cultivated at high temperature. Studies like these show that the OSMAC
approach can be used on diatoms as well as bacteria.
Changing cultivation conditions for microorganisms is a way of mimicking natural
cultivation conditions in the laboratory. In nature, microorganisms like diatoms coexist
with a plethora of other organisms. There is a constant competition between species com-
peting for the same recourses, as well as pressure from predators. The concentration of
diatoms in the ocean fluctuates throughout the year. During the annual spring bloom in
Northern Temperate and Arctic waters the diatoms dominate the phytoplankton commu-
nity, reaching concentrations up to 6–10 × 106 cells L−1 [14]. The diatom bloom is followed
by an increase in the number of grazing mesozooplankton such as copepod species [15,16],
and microzooplankton such as heterotrophic protozoans, dinoflagellates and flagellates.
Diatoms have for many decades been regarded as the main food source for many zooplank-
ton species and are highly important for the transfer of nutrients up the food chain [17,18].
This relationship has been challenged after several studies found possible toxic effects on
copepods feeding on diatoms [19–28]. These studies have investigated the effect of diatom
species such as Phaeodactylun tricornutum, Pseudo-nitzschia delicatissima, Thalassiosira gravia
and Thalassiosira rotula, and about 10 other species. Studies have revealed reduced hatching
success in copepods fed a diet of T. rotula, and during a bloom of Skeletonema costatum and
P. delicatissima [29,30]. Chaudron et al. [31] found that an increasing proportion of the di-
atoms P. tricornutum and T. rotula in the diet led to a reduction in hatching success. Diatoms
in the diet can have an insidious effect, i.e., affecting the offspring rather than the consumer
itself, and Poulet et al. [32] found teratogenic effects on nauplii larvae leading to fatal ab-
normalities. The compounds that have been deemed culprits in many of these studies are
oxylipins, especially polyunsaturated aldehydes (PUAs) [30]. PUAs are not synthesized in-
side the cells, but are rather produced enzymatically by lipoxygenase/hydroperoxide lyase
from polyunsaturated long chained fatty acids seconds after the rupture of cell membranes
due to feeding [27,33]. On the other hand, studies have shown that copepods release chemi-
cal signals and cues, often polar lipids called copepodamides, that can trigger a response in
microalgae [34,35]. Copepodamides have been shown to affect the morphological features
of Skeletonema marinoi, such as a decrease in chain lengths [36,37]. Other reported effects on
diatoms have been an induced production of the toxin domoic acid by Pseudo-nitzschia [38].
Based on the aforementioned studies it is therefore reasonable to think that diatoms can
be affected by stress and thus alter their biochemistry, and we hypothesized that diatoms
could change their metabolite expression in response to grazing pressure. Metabolomics
can be used to investigate the diatoms at a specific time under specific conditions, e.g.,
when exposed to grazing pressure, in order to reveal changes in the metabolome [39,40].
Further, we hypothesized that such changes in metabolic expression could be detected
as a change or an increase in bioactivity in cell-based bioassays; bacterial growth inhi-
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bition assays, the inhibition of biofilm formation and the viability of human cell lines,
and that grazing pressure could trigger the production of compounds leading to higher
bioactivity. Inducing stress in diatom cultures by cocultivation with zooplankton could
thus be a potential new “tool” in the OSMAC toolkit, i.e., a method to discover new
bioactive metabolites.
In this study we cultivated the marine temperate diatom Porosira glacialis (Grunow)
Jörgensen 1905 in a large photobioreactor (PBR), first as a monoculture and then in coculture
with zooplankton from a nearby costal bay. More specifically the aim of the study was to
investigate whether the presence of a small but varied grazer population could alter the
P. glacialis’ biochemistry and bioactivity.
2. Results
2.1. Cultivation of P. glacialis and Cocultivation with Zooplankton
Four nonaxenic batch cultures were cultivated during the experiment: two monocul-
tures abbreviated Pg1 and Pg2 and the two coculture samples abbreviated PgZ1 and PgZ2.
All were closely monitored to keep track of whether the cells were healthy and that we
had no contamination of unwanted organisms in the culture tanks. All cultures were in
good growth condition throughout the cultivation period (Figure 1). Before harvest of the
coculture, 10 × 1 L of the culture was transferred to clear flasks to enumerate the number
of zooplankters per liter of culture. The concentrations of animals were 1.5 individuals
L−1 for PgZ1 and 1.0 L−1 for PgZ2. The growth data of diatoms based on cell counts
(Figure 1) showed that all cultures, except for PgZ2 (growth rate 0.1 doubling day−1),
had a steady increase in cell numbers (growth rates 0.29–0.33 doublings day−1), and were
all harvested during the exponential growth phase when the cell numbers had reached
12–15,000,000 cells L−1. The second coculture, PgZ2, obviously had a lag phase, but had
started the exponential phase when it was harvested after four days. Harvest at a lower cell
count was done due to time limitations on the experiment. See Supplementary Material for
data on growth rates, temperature, pH, and nutrient concentrations (Figures S2–S6).
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Both zooplankton batches were dominated by two genera: the cyclopoid copepod Oithona sp.
and the calanoid copepod Pseudocalanus sp. (Table 1). PgZ1 had a higher diversity than
PgZ2, and ore species could therefore be identified. A few speci ens of Oithona sp. fro
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Table 1. Species identification and composition (%) of both zooplankton batches. Details on zoo-




Acartia longiremis 10.0 -
Calanus finmarchicus 2.6 -
Calanus nauplius - 2.3
Centopages typicus 1.3 2.3
Metridia longa 0.3 -
Microcalanus sp. 2.4 -
Oithona sp. 65.1 53.5
Pseudocalanus acuspes/sp. 16.4 39.5
Temora longa 0.2 -
Calanoida, uid juvenile 1.0 -
Paraeuchaeta norwegica - 2.3
Bryozoa/cyphonautes 0.8 -
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fraction also showed activity against the A2058 for one of the cocultures (PgZ2) as de-
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ce l human colon carcinoma, A2058 human melanoma, and MRC5 normal lung
fibroblasts in a cell viability assay at 50 µg mL−1 (Figure 4). As the figure shows, activity
was found against all three cell lines. Towards the HT29 colon carcinoma cells, the activity
profile of the fractions from the different cultures were similar; the only difference was
ob erved for Pg1, where both organic d queous fraction 5 were active (Figure 4a,b).
Towards the melanoma cell line A2058, only organic PgZ2 fraction 6 showed activity
(Figure 4c). No differ nce in the activity betwe n the two cultivati
other fractions as etected. The bioactivity profile against the or al cell li
reveal iff r c bet een monoculture and coculture samples; organic fraction 6 of the
PgZ1 and 2 were active against the cells, while Pg1 and 2 were not (Figure 4e). This fraction
also showed activity against the A2058 for one of the cocultures (PgZ2) as described above.
The bioactivity profile against HT29 shows that organic fraction 6 of PgZ1 and 2 also had
some effect on human colon carcinoma compared to Pg1 and 2.
2.5. Bacterial Growth Inhibition Assay
All samples were tested in a growth inhibition assay against the five bacterial strains
Staphylococcus aureus (ATCC 25923), Escherichia coli (ATCC 25922), Pseudomonas aeruginosa
(ATCC 27853), Escherichia faecalis (ATCC 29212) and Streptococcus agalactiae (ATCC 12386)
at 50 µg mL−1. The results in Figure 5 showed that fraction 5 (both organic and aqueous)
from all four samples was active against one of the strains, Streptococcus agalactiae. There
was no activity against the other strains, and no difference in activity of the two cultivation
treatments. This showed that grazing pressure had no obvious effect on antibacterial
activity of P. glacialis.
2.6. Metabolic Profile
Crude extracts of all samples (organic and aqueous) were analyzed using UHPLC and
HR-MS to obtain metabolic profiles of the extracts. The UHPLC-HR-MS chromatograms of
the extracts were very complex, and in order to identify differences between the different
samples, we analyzed the data in a metabolomics workflow. The scores’ plots (Figure 6) are
based on the collected markers (i.e., combinations of a mass and a retention time) from all
samples. The monoculture and coculture samples were well separated both for the organic
samples (Figure 6a) and the aqueous extracts (Figure 6b), showing that there are variations
in the metabolic profiles of the two cultivation conditions. All monoculture samples
clustered together, meaning that there was little variation within the group. The two
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different coculture samples (i.e., PgZ1 and PgZ2) grouped separately for both the organic
and aqueous extracts, indicating that there were some differences in metabolic profiles
between the two cultivations. However, as we did not observe any significant differences
in bioactivity between these two cocultivations, we assume that the difference is due to
variations in cultivation temperature, as sample PgZ2 was cultivated at lower average
temperature than the others.
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Elemental composition calculations of the markers were done using HR-MS data in ES+.
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contribution. Markers highlighted in red are those where a matching compound was identified.
The two markers in the coculture samples m/z 641.4193 and m/z 599.4088 were
identified as the carotenoids halocynthiaxanthin acetate (C42H56O5) and halocynthiax-
anthin (C40H54O4), respectively. Both compounds were previously isolated from ma-
rine sources [41]. A third carotenoid with m/z 563.388 was identified as clathriaxanthin
(C40H50O2), which has been isolated from marine sponges [42,43]. Two of the markers
in the monoculture samples were identified as chlorophyll derivatives. The marker m/z
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623.2855 (C36H38N4O6) was suggested to be a pheophorbidelike structure and marker
m/z 535.2706 (C33H34N4O3) as pyropheophorbide b. The compound with m/z 456.2789
and elemental composition C27H37NO5 corresponded with a compound earlier found in
marine derived fungi [44].
The active fraction 6 of PgZ1 and PgZ2 were analyzed using UPLC-HR-MS to search
for compounds responsible for the activity. The chromatograms of the active fractions were
compared to the nonactive fraction 6 of Pg1 and Pg2 to search for possible differences.
No apparent differences were found in the chromatograms with respect to the presence of
the more prominent metabolites, but there were numerous cases where the signal strength
of compounds varied between the active and the inactive fractions. The max fold change
of the total number of compounds found in the metabolomics dataset (of all four samples)
showed that 4972/14280 compounds had a noticeable upregulation (fold change cut off
> 5). Due to the high number of compounds with differences in abundances, it was not
possible to attribute the differences in bioactivity to any specific metabolite. However,
the manual dereplication resulted in finding signals corresponding to degradation products
of chlorophyll such as pheophorbide and membrane components such as phosphocholines
among the prominent metabolites.
3. Discussion
The aim of the present study was to investigate if the presence of a small but varied grazer
population could alter the P. glacialis biochemistry and bioactivity, i.e., to evaluate if zooplankton
grazing could be applied as a tool to induce the production of bioactive compounds.
Extracts of biomass cultivated with and without the presence of zooplankton were
tested in three different bioactivity assays: human cancer cell viability, bacterial growth
inhibition and inhibition of bacterial biofilm formation. The screening of the flash-fractions
was done at a concentration of 50 µg mL−1, allowing comparisons of activity between
fractions and assays. Fractions that were active at 50 µg mL−1 were retested at different
concentrations after serial dilutions to evaluate dose–response effects. Using the same
test concentrations of all the fractions in the initial screening allowed us to assess possible
differences between the different cultivation conditions. All samples showed activity
in all performed assays, confirming the bioactivity previously found in P. glacialis by
Ingebrigtsen et al. [13].
As diatoms are known to change their bioactivity and metabolic profile in response
to changing cultivation conditions such as light, temperature and nutrients [12,13,45]
we aimed to minimize variations in cultivation conditions in order to prevent cultures
from being influenced by changes other than the presence of the grazing zooplankton.
Our experiment was carried out in a 6000 L vertical column mesocosm bioreactor at a
cultivation facility located outdoors. Being located outdoors, the temperature of the cul-
tures was dependent on the air and water temperature of the season, but as the experiment
was conducted during winter the temperature was relatively stable, i.e., average cultiva-
tion temperatures were 4.3–5.4 ◦C during the cultivation of cultures Pg1, PgZ1 and Pg2.
Only one culture, PgZ2, had a lower average temperature (1.0 ◦C). Temperature change
has been shown to influence the antioxidant activity of P. glacialis but did not have any
effect on anticancer activity [13].
Several calanoid copepods are known to enter hibernation and nonfeeding (diapause)
during winter when the concentrations of microalga in the water column are negligible [46].
As our experiment was performed during winter, it was uncertain how our added zoo-
plankton sample would react to the transition from dark, clear water to a dense diatom
culture with 24 h illumination. Our investigation of the copepods under the microscope
showed that they were still alive at the end of each cultivation period. Visual inspection of
all the investigated specimens also confirmed that they were feeding on the diatoms. Fur-
thermore, the fecal pellets found in the same samples contained partly digested P. glacialis.
Previous studies have revealed that the small copepod Oithona sp., one of the dominating
species in the samples, remains active during winter, feeding on what they find [47–49].
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We thus concluded that the zooplankton were actively grazing on the diatoms. Regarding
the total effect of the presence of grazing zooplankton on P. glacialis we also need to consider
the concentration of zooplankton in the culture. At the peak of zooplankton abundances
during the spring bloom, the number of copepods can be > 100 L−1 [38,50]. Such high
concentrations constitute a major grazing pressure on the diatoms and other microalgae.
Our experiment was performed with a concentration of 1–1.5 specimens per liter of culture,
which in comparison is very low, especially when the diatom concentrations are considered.
However, copepods can scare many more prey than they consume [37,51]. In addition,
it is important to consider that the zooplankton was added to a monoculture of P. glacialis
which had been growing without competition from any other species of phytoplankton
or zooplankton for a long period of time. Although our samples were sieved, a higher
concentration of zooplankton could have resulted in the extraction of metabolites from
zooplankton, and not P. glacialis as was our aim. As we managed to keep conditions similar
between treatments, and at an early stage of the experiment obtained evidence that the
zooplankton were grazing on P. glacialis, we expect that the differences we observed were
due to the presence of zooplankton.
The results from the bioactivity testing against bacteria revealed no significant differ-
ence in the bioactivity of the two cultivation conditions (p > 0.05 for all samples, statistical
analysis in Table S2). The inhibition of biofilm formation assay revealed 14 active fractions
in total, 9 from monoculture samples vs. 4 from coculture samples. As the results of
the assay were based on the amount of biofilm present after 24 h of exposure to the flash-
fractions, it cannot be excluded that the activity was due to growth inhibition of the bacteria
itself rather than inhibition of biofilm formation. This can only be ruled out by a growth
inhibition assay, which should be performed if the results of the biofilm activity assay are
to be studied further. There were more active fractions from the monoculture samples,
but the activity profile of the tested fractions showed similar patterns in all samples tested.
These similarities could indicate that the difference in activity was due the concentration
of active component in the fractions, and not due to different components in the fractions
from the two different cultivation treatments. Bioactivity against the formation of bacterial
biofilm in diatom extracts has been investigated to a lesser extent, and there are few studies
showing the biofilm activity of marine diatoms [12]. Such activity can be a strategy by
the diatoms to prevent bacterial growth on the surface of the diatom, in its phycosphere
or immediate surroundings, but the stress of grazing pressure has no apparent effect
on P. glacialis’ ability to inhibit the formation of biofilm. Large scale microalgal cultures
will always contain bacteria. Bacteria are in fact often beneficial in diatom cultivation,
and necessary to provide certain compounds needed by the diatoms, such as vitamin B12,
iron and other trace elements [52]. The production of antibacterial compounds by the
diatoms might not be beneficial when the bacteria present are not parasitic or in any way
harmful for the diatoms. The presence of grazers such as copepods, on the other hand,
might induce stress reactions in the diatoms that could lead to the synthesis of secondary
metabolites with activity that could also have antibacterial effects. Our experiment showed
no significant difference in antibacterial effect between the two cultivation conditions,
and the total number of active fractions in the growth inhibition assay was low (5/64).
All samples were screened in a viability test against two cancer cell lines, human
colon carcinoma and human melanoma, and activity was found against both cell lines.
Cytotoxic activity in extracts of marine diatoms is known from previous studies [12,13],
but the compounds responsible in those studies has not been identified. Sansone et al. [53]
found anticancer activity against A549 (ATCC CCL185) human lung adenocarcinoma and
COLO 205 (ATCC CCL-222) colon adenocarcinoma when exposing the cell lines to the
diatom-derived PUAs 2-trans, 4-trans-decadienal, 2-trans,4-trans-octadienal and 2-trans,4-
trans-heptadienal, all of which had anticancer activity, and no activity against the normal
lung/brunch epithelial BEAS-2B cell line. Although activity was observed against both
cancer cell lines, the activity profile showed no significant difference between the cultivation
treatments, indicating that cocultivation with zooplankton had no obvious effect on the
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anticancer activity of P. glacialis. The viability assay was also conducted against normal lung
fibroblasts (MRC5). This viability assay revealed a difference between the two cultivation
treatments. Organic fraction 6 of PgZ1 and 2 were active and led to a decrease in cell
viability, while fraction 6 of Pg1 and 2 had no effect on the cells. The same fraction also
showed activity against A2058 for PgZ2. This shows that the presence of zooplankton
induced the production of compound(s) that are toxic against normal lung fibroblasts. In a
study by Ingebrigtsen et al. [54] field samples of microalgae and zooplankton from a spring
bloom in the Barents Sea were screened for bioactivity and compared to a monoculture
of P. glacialis. In the study, field samples composed of only microalgae, only zooplankton
and the two combined were all active against normal lung fibroblasts, while the cultivated
monoculture of P. glacialis was not active in the same assay. These results compared to those
from the current study might suggest that diatoms under stressful conditions produce
compounds that are toxic to normal human cell lines. The active fractions were analyzed
using UPLC-HR-MS to search for possible differences that could reveal which compounds
were responsible for the activity in fraction 6 of PgZ1 and PgZ2. Dereplication of some
prominent peaks of the chromatograms revealed signals corresponding to chlorophyll
derivatives such as pheophorbide and membrane components such as phosphocholines.
Pheophorbidelike compounds has previously been shown to have anticancer and cytotoxic
properties [55]. In the metabolomic analysis of the extracts, several carotenoid compounds
were found to contribute most to the differences in the cocultivated samples. Carotenoids
such as fucoxanthin have shown anticancer activity in previous studies both in diatoms
and green algae [56–58]. Analysis of the chromatograms revealed no apparent differences
in metabolite composition, but rather a difference in the concentration of the metabolites,
based on the signal strength of the peaks in the chromatogram. The fractions are highly
chemically complex, and pin-pointing a culprit responsible for the specific cytotoxicity is
difficult. However, based on evidence found in the LC-MS analysis of active fractions and
metabolomics samples, the cytotoxicity might be attributed to chlorophyll degradation
products or carotenoid compounds.
Grazing copepods are known to influence diatom morphology [36,59] and biochem-
istry [38]. Amato et al. [60] investigated the metabolomic and transcriptomic changes in
Skeletonema marinoi after cocultivation with Calanus finmarchicus and Centropages typicus and
found that there was an activation of stress response, and a change in lipid and nitrogen
metabolism of the diatoms. Our analysis of the metabolomic data and metabolic profiles of
the organic extracts show a difference between the samples from the monocultures and
the cocultures, but this difference might not be detectable as a change in the bioactivity of
the samples. Initial attempts to identify the compounds contributing the most differences
were done. In the monoculture samples the markers were identified as a possible alkaloid
and two pheophorbidelike compounds. Pheophorbide has been linked to grazing, as it is
a pigment often found in fecal pellets of copepods due to the degradation of chlorophyll
in the stomach [61]. In addition to phaeophytin a, pheophorbide is a known degradation
product of chlorophyll a that we expected to be present in our samples [62]. Analysis
of the stress response by Amato et al. [60] showed the downregulation of chlorophyll
binding proteins when the diatom Skeletonema marinoi was exposed to copepod grazing.
The compounds contributing most to the difference in the coculture sample set were iden-
tified as carotenoids. Carotenoids are one of the most abundant groups of pigments in
nature, and play important roles in many physiological functions [63]. In addition to being
color compounds and accessory pigments in the photosynthesis, they are also known as
antioxidants and UV protecting molecules [64,65]. Former studies have shown that algae
and higher plants increased the production of carotenoids in response to stresses such as
UV light associated damage, nutrient depletion, pH and temperature [65–68]. Although no
studies were found relating grazing stress to the production of carotenoids it is plausible
that this may have a connection.
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In conclusion, the present study reveals that grazing zooplankton have an effect on the
temperate diatom P. glacilias, and that the effect can be seen in both the metabolic profile
and the expressed bioactivity.
4. Materials and Methods
4.1. Mass Cultivation of Porosira Glacialis
Two nonaxenic batch cultures of P. glacialis were cultivated at an outdoor mass culti-
vation facility, in a 6000 L glass fiber vertical column open photobioreactor. As irradiance
from natural light is scarce and the solar angle is low during winter in Northern Norway
(69◦13′0′ ′ N, 18◦5′10′ ′ E), the cultures were illuminated using LED light (500–700 W) at
photoperiod 24 h to provide consistent light conditions. Seawater used in the cultivations
was from an inlet at 25 m depth filtrated through a series of filters; 5 µm particle filter (Azud,
Murcia, Spain), 1 µm filter cartridge (Eaton, Dublin, Ireland) and a UV unit (450 mJ cm−1
at 12 m3 t−1) (ULTRAAQUA A/S, Aalborg, Demark). Silicate solution and inorganic
nutrients (N, P, Mg, K, S and Fe) were added in order to allow the microalgae to grow at nu-
trient replete conditions. Daily measurements of nutrient concentrations (NO3−, SiO2 and
PO43−), temperature (◦C) and pH were done to monitor cultivation conditions. In addition,
biomass concentrations were inferred by cell counts [69] and chlorophyll concentration
measurements (raw fluorescence). Daily visual examination was performed to assess
culture health using an inverted microscope (Zeiss Axiovert A1, Carl Zeiss Microscopy
GmbH, Jena, Germany). Diatom biomass was harvested after 5 days of growth using a
continuous centrifuge (Evodos 10, Evodos B.V., Raamsdonksveer, The Netherlands), frozen
immediately after harvest and kept at −80 ◦C until further use. After the first harvest the
diatom culture was diluted and prepared for the zooplankton challenge experiment.
4.2. Zooplankton Collection
Samples of zooplankton were collected near the shore in Finnfjordbotn in Northern
Norway (Figure 8) using a WP2 plankton net (180 µm) with a detachable cod-end. The net
was towed at ca. 1 knots towing speed just below the surface at the side of a Polarcircle 560
Work boat. Each WP-2 haul lasted for about 20–30 min before the net catch was emptied
into sample flasks. The transfer was done quickly due to low air temperature (ca. −13 ◦C)
and risk of sea water freezing. All net samples were pooled and stored at approximate
seawater temperature at the sampling site, i.e., 2 ◦C in an insulated container onboard
until use (2–4 h). Larger species, such as ctenophores were removed from the sample.
Subsamples were preserved in 96% ethanol and stored for taxonomic analysis.
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4.3. Cocultivaion
The collected zooplankton sample was transferred to the 6000 L open photobioreactor
containing the P. glacialis monoculture. P. glacialis was cocultivated with the field zooplank-
ton sample. The other cultivation parameters and daily measurements were the same as
for the monoculture. As a survival control, flasks (2 L) with the coculture of P. glacialis
and the zooplankton sample were kept in a cultivation incubator in the lab at 4 ◦C with
a photoperiod of 14:10 (light:dark) to monitor if the zooplankton survived in the dense
culture. Feeding/no feeding was monitored by inspecting zooplankton gut content after
2 days, using an inverted microscope at 100× magnification (Zeiss Axiovert A1, Carl Zeiss
Microscopy GmbH, Germany). Figure 9 shows an overview of the cultivation and coculti-
vation pipeline. For each cocultivation new zooplankton bulk samples were collected from
a nearby bay area. The harvest of the coculture was done using a continuous centrifuge
(Evodos 10, Evodos B.V., The Netherlands), but the culture was filtered through a plankton
net (180 µm) prior to the centrifugation to make sure that zooplankton were kept from
entering the centrifuge. Harvested biomass was frozen immediately and kept at −80 ◦C
until use.
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Figure 9. Overview of experimental workflow.
4.4. Extraction and Flash-Fractionation
All diatom biomass for bioactivity testing was freeze-dried, ground into a fine powder
using mortar and pestle, and extracted overnight using MilliQ-H2O. It was then centrifuged
at 4600 rpm and 4 ◦C for 30 min, and the supernatant was kept. The pellet was resuspended
in MQ-H2O and extracted a second time for 30–60 min, and centrifuged. The supernatant
was frozen at −80 ◦C, then freeze-dried and ground into a fine powder before being frozen
at−20 ◦C. The extracted pellet was freeze-dried before being extracted overnight using a 1:1
mixture (vol:vol) of methanol (Sigma-Aldrich, St. Louis, MO, USA) and dichloromethane
(Merck, Darmstadt, Germany). The extract was filtered, and the pellet was extracted a
second time. The combined organic extract was dried under reduced pressure using a
rotavapor (Laborata 4002, Heidolph Instruments GmbH, Schwaback, Germany).
Aqueous and organic extracts were fractionated using a flash purification system
(Biotage HPFC SP4, Biotage®, Uppsala, Sweden). Organic extracts were prepared by
suspending 1.5 g of extract in Hexane (40 mL g−1) in a separation funnel. MeOH (90%) was
added (30 mL × 2), the solution mixed carefully, and the lower liquid phase (MeOH) as
transferred to a round flask prefilled with 2 g of Dianon HP-20SS resin (Supelco, Bellefonte
PA, USA) and dried under reduced pressure. Aqueous extracts were prepared by mixi g
2 × 0.75 g of ried extract with 4 mL 90% MeOH, 1.5 g Dianon HP-20SS resin and 1 mL
MilliQ-H2O, before being dried at reduced pr ssure.
Columns for flash-fractionation wer prepared by washing 6.5 g of resin with MeOH
for 20 min. MeOH was then exchanged with MQ-H2O, and t e material wa transferred to
a flash column (Biotage® SNAP, Uppsala, Sweden). The column was equi ibr ted with 5 %
MeOH, and the dried extract was loaded to the column. Flash fractionation of the sample
was done in two steps; first with a gr dient of 5–100% MeOH and MilliQ-H2O at a flow
r te of 12 mL min−1 for 32 min, and then a MeOH:acetone (Merck, Germany) gradient
ending 100% acetone, flow rate 12 mL min−1 ov r 18 min. The eluent was collected
into eight fractions and dried unde reduced pressure. Fractio s w r dissolved in 100%
DMSO to a concentration of 40 mg mL−1. Deep well screening plates were prepared by
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adding 25 µL (i.e.,1 mg dry material) of each fraction and stored at −20 ◦C until screening.
Fractions were resuspended in 975 µL dH2O right before screening.
4.5. Biofilm Assay
All flash-fractionated samples were tested for inhibition of biofilm formation using
the bacterial strain Staphylococcus epidermidis (ATCC-35984) which is known to form biofilm.
Bacterial colonies were transformed from blood agar to a liquid Tryptic Soy Broth enrich-
ment media (TBS, Merck, Germany) and incubated at 37 ◦C overnight, and then diluted
1:100 in TBS + 1% glucose. The assay was performed in 96-well microtiter plates at a
concentration of 100 µg/mL, and all fractions were tested in triplicates. 50 µL of each
fraction and 50 µL of bacterial suspension was added to each well. The nonbiofilm forming
bacteria Staphylococcus haemolyticus was used as negative control, S. epidermidis + dH2O as
a positive control and TBS (1% glucose) and dH20 as blank. Plates were incubated at 37 ◦C
overnight. The bacterial suspension was removed carefully, and the wells were washed
using MQ-H2O. To fixate the biofilm, the plates were stored at 55 ◦C for an hour. Then the
biofilm was stained using 70 µL of 0.1% crystal violet (Merck, Germany) for 5 min. The liq-
uid was removed by repeated washing with MQ-H20, dried at 55 ◦C, and resuspended
using 70% EtOH. Absorbance was read in a VICTOR 1420 Multilabel Counter (Perkin
Elmer, Waltham, MA, USA) at 600 nm.
4.6. Growth Inhibtion Assay
Antibacterial activity was investigated in a growth inhibition assay. A panel of five
different bacterial strains were used, and both Gram negative and positive bacteria were
included. Colonies of Staphylococcus aureus (ATCC 25923), Escherichia coli (ATCC 25922)
and Pseudomonas aeruginosa (ATCC 27853) were transferred from blood agar plates an inoc-
ulated at 37 ◦C for 24 h in Mueller–Hinton growth media (MH, Becton Dickinson Company,
Franklin Lakes, NJ, USA), and Escherichia faecalis (ATCC 29212) and Streptococcus agalactiae
(ATCC 12386) in brain heart infusion media (BHI, Sigma-Aldrich, Germany). After incu-
bation 2 mL of each suspension was transferred to 25 mL of fresh growth medium and
incubated until log-phase, before being diluted to 1:1000 to adjust cell density. The assay
was performed in 96-well titer plates at 100 µg mL−1. 50 µL of each fraction and 50 µL
of bacterial suspension was added to each well. All fractions were tested in duplicates.
Growth medium + dH2O was used as negative control, and gentamicin was used as posi-
tive control. The plates were incubated at 37 ◦C overnight and absorbance was measured
in a VICTOR 1420 Multilabel Counter at 600 nm.
4.7. Cell Viability Assay
The flash fractions were tested against two cancer cell lines: human melanoma (A2058,
LGC Standards ATCC-CRL-11147) and human colon carcinoma (HT29, LGC Standards
ATCC HTB-38), and for comparison, against normal lung fibroblasts (MRC5, LGC Stan-
dards ATCC CCL-171). 2000 cells were seeded into each well of a 96-well micro titer plate
(4000 cells/well for MRC5 cell line) in Roswell Park Memorial Institute 1640 cell medium
(RPMI) with 10% fetal bovine serum added 10 mg mL gentamicin and incubated at 37 ◦C
and 5% CO2 for 2 h. After incubation the medium was replaced with 50 µL per well
and the cells were exposed to 100 µg mL−1 of flash fractions for 72 h. All fractions were
tested in triplicate. Culture medium was used as a negative control, while 10% (v/v) DMSO
(Sigma-Aldrich, Germany) was used as the positive control. At the end of incubation,
10 µL of CellTiter 96 Aqueous One Solution Reagent (Promega, Madison, WI, USA) was
added and incubated for 1 h. Then the absorbance was read at 485 nm using a DTX 880
Multimode Detector. Results were calculated as % cell survival, and survival below 50%
was counted as active.
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4.8. UHPLC-ESI-HR-MS Analysis and Data Processing for Metabolomic Profile
The UPLC-HR-MS analysis was done using a Waters Acquity I-class UPLC system
(Waters, Milford, MA, USA) coupled to a PDA Detector and a VION IMS-qTOF, using
electrospray ionization (ESI) in positive mode. Wavelengths from 190–500 nanometers
were detected. VION IMS-qTOF conditions for UPLC-HR-MS analysis; capillary voltage
(0.80 kV), cone gas (50 L h−1), desolvation temperature (350 ◦C), desolvation gas (800 L h−1),
source temperature (120 ◦C) and acquisition range was m/z 50–2000. Chromatographic
separation was performed with a BEH C18 1.7 µm (2.1× 100 mm) column (Waters, Milford,
MA, USA) maintained at 40 ◦C. Data from the analysis of flash fractions were processed
using UNIFI 1.9.4 software (Waters). Selected peaks were dereplicated using MarinLit,
ChemSpider, and Dictionary of Natural products, as well as extensive literature searches.
Statistical analysis of metabolomics data was done using EZinfo v.3.0.3.0 (Umetris ab) and
Progenesis QI v.2.4 (Nonlinar Dynamics) software for analysis of LC-MS data. Scores plot
and s-plot were made using EZinfo.
4.9. Statistics and Software
Statistical analysis of data was done by running chi-square tests in Excel for Mac 2020
version 16.36. Figures were made using Prism 8 for Mac (GraphPad Software Inc.) and in
Rstudio version 1.2.1335 [70]. Map was made with Maps version 3.1.1. in R version 3.3.2. [71].
5. Conclusions
Investigation of the metabolic profiles from the monocultures and the cocultures
revealed metabolomic differences indicating that stress from grazing affected, e.g., the pro-
duction of carotenoids in P. glacialis. Cocultivation with zooplankton also induced the
production of compounds with cytotoxic activity towards normal lung fibroblasts. Using
cocultivation to enhance or trigger the production of bioactive compounds in bacteria
is quite common and this method can also be used in microalgae biodiscovery. Future
OSMAC studies on diatom and zooplankton cocultivation should include cultivation also
using alternative species of diatoms and zooplankton, as well as different concentrations of
grazers and cultivation at other times of the year. Full genome sequencing of diatoms has
revealed that their large genomes most likely harbor “silent” gene clusters. It is therefore
reasonable to believe that diatoms have a greater potential to produce secondary metabo-
lites than what emerges in “static” laboratory conditions and cultivation in monoculture.
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Supplementary Figure S1. Panel showing temperature and salinity profiles from the 
two sample sites where we collected zooplankton. The lower x-axis shows salinity as 
PPT with red dots and the upper x – axis shows temperature in degrees Celsius (°C) 
with blue dots, while the y-axis is depth in meters. CTD casts data were taken from 
surface to 50 cm above bottom and back to surface. Samples sites were similar, and 
the water column was well-mixed at both sites. 
 
Supplementary Table S1:  Zooplankton composition of bulk zooplankton samples. 
Zooplankton sub-samples were collected before zooplankton were added to culture 







Species Samples 1 (PgZ1) Samples 2 (PgZ2) Count % Comment Count % Comment  
Acartia longiremis 62 9,98 mostly adult female    
Calanus finmarchicus 16 2,58     
Calanus nauplius    1 2,33  
Centopages typicus 8 1,29 copepodites 1 2,33  
Metridia longa 2 0,32     
Microcalanus sp 15 2,42 copepod/adults    
Oithina sp. 404 65,06 most stages 23 53,49  
Pseudocalanus acuspes/sp 102 16,43 copepod/adults 17 39,53 5 females 
Temora longa 1 0,16 copepodite    
Calanoida, uid juvenile 6 0,97 mostly adult females 1 2,33  
Paraeuchaeta       
Bryozoa/cyphonautes 5 0,81     
Total 621 100  43 100  
 
 
Supplementary Figure S2: Daily temperature measurements (in °C). 






Supplementary Figure S3: Daily pH measurements. The pH was 
measured daily in all cultures using a pH meter just below the surface 
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Supplementary Figure S4: Daily nitrate measurements of all cultures (in 
mg/L). Nitrate concentration was measured using SpectroquantÒ 





Supplementary Figure S5: Daily silicate measurements of all cultures 
(in mg/L). Silicate concentration was measured using SpectroquantÒ 
Silicate (Silicic Acid) Test (Merck KGaA, 64271 Damstadt, Germany) 
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Supplementary Figure S6: Daily phosphate measurements of all 
cultures (in mg/L). Phosphate concentration was measured using 




Supplementary Table S2. Chi-square table showing p-values of the total number of 
active Flash - fractions versus inactive flash fractions between the different treatments. 
 
Sample 
Content Pg1 Pg2 PgZ1 PgZ2 
Pg1 - 0.426 0.426 0.273 
Pg2 0.426 - 1.000 0.426 
PgZ1 0.426 0.759 - 0.759 
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Bacterial biofilms are produced in order to protect the cells against antibacterial treatment, to 
facilitate interspecies communication and horizontal gene transfer, in addition to make 
nutrients readily available for the bacteria embedded in the biofilm. Biofilms are formed on 
nearly any possible surface making it a widespread issue, causing problems such as both 
infections and biofouling on installations in the aquatic environment. It is therefore desired to 
find effective treatments for removal of biofilm. Marine diatoms live in close relationship with 
bacteria. Though some diatom species are known to form biofilm themselves, previous studies 
of marine diatoms have reported inhibition of biofilm formation by bacteria. In the present 
study the anti-biofilm activity towards Staphylococcus epidermidis by the marine temperate 
diatom Porosira glacialis was investigated. Bioassay guided isolation resulted in isolation of 
two compounds that were able to inhibit biofilm formation: methyl 3-hydroxyoctadecanoate 
and a pheophorbide like compound. This is the first report on anti-biofilm compounds isolated 
from P. glacialis.  
Introduction  
Bacterial biofilms are sessile prokaryotic communities encapsulated in a three-dimensional 
exopolymer matrix in a moist environment. The matrix can consist of a variety of different 
 2 
biopolymers (i.e. polysaccharides, proteins, lipids, teichoic acid and nucleic acids) known as 
extracellular polymeric substances, and is synthesized by the bacteria themselves [1, 2]. 
Formation of biofilm has a wide range of advantageous functions for the bacteria within. The 
biofilm facilities adhesion, it creates cohesion which in turn creates opportunity for transfer of 
genetic information as well as intracellular communication. In addition, it serves as a trap for 
nutrients, provides protection against desiccation and protects the bacteria against exposure to 
antibacterial compounds, grazing and host immune systems [1, 3-7]. The formation of the 
biofilm is a multi-step process starting with bacterial attachment to a surface. Once the bacteria 
are attached they start synthesizing and excreting EPS, divide and eventually form a mature 
biofilm which can be seen as a slimy layer covering moist or submerged surfaces [7, 8]. The 
mature biofilm can detach and spread to form biofilm elsewhere.  
 
Biofilm formation can occur on nearly any submerged surface where bacteria are present, and 
it is suggested that more than 90% of bacteria naturally exist within biofilms [9-11]. Biofilm 
forming bacteria can cause issues in a range of areas from nosocomial infections to biofouling 
on ship hulls and other installations submerged in the aquatic environment [12, 13]. 
Nosocomial infections are often caused by bacteria forming biofilm on medical implants such 
as artificial hip joint, breast implant and catheters [13-15]. Biofouling in the marine 
environment start with the formation of marine biofilm bacteria and microalgae, before 
settlement of larger species such as macroalgae and mussels. Such growth can cause problems 
for e.g. ships by increasing frictional drag thus leading to increased fuel consumption, as well 
as increasing cost related to painting, cleaning and general maintenance [16, 17] The variety 
of issues caused by biofilm forming bacteria illustrates a need for new and effective treatments.  
 
Bacterial strains that are usually sensitive to antibiotics can increase their susceptibility when 
embedded in a biofilm. Compared to free-living bacteria, being protected by a biofilm, bacteria 
can be up to 1000 times more resistant towards traditional antibiotic treatment [18]. One 
example is a b-lactamase negative strain of Keibsiella pneumoniea which, in planktonic state, 
has a MIC of 2mg mL-1. When protected by the biofilm matrix, >50% survived a 4h treatment 
with 500mg mL-1 [19]. Research has shown that it is not the normal mechanisms of antibiotic 
resistance (e.g. efflux-pumps, mutations or modified enzymes) [20] that make the biofilm 
resistant. It is rather that the biofilm causes a slow penetration of the antibiotics, that an altered 
chemical environment inside the biofilm affects the effect if the antibiotics [21]. In addition, 
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the mutation frequency and horizontal gene transfer is significantly increased in biofilm 
forming bacteria, which could be one of the factors contributing to multi-resistant strains [18, 
22, 23]. 
 
Diatoms and their predecessors co-evolved with bacteria. There is also evidence that many 
diatom genes were acquired from bacteria [24-26]. However, only a few groups are known to 
be regularly associated with diatoms such as Alpha, Beta and gammaproteobacteria and 
bacteriodetes, and these are represented by only a few taxa [24, 27, 28]. Some bacteria are 
shown to be commensialists that provide diatoms with much needed vitamins and trace 
elements in exchange for dissolved carbon and nitrogen compounds [26]. Diatom – bacteria 
interactions also include competitive interactions where bacteria sometimes are better at 
scavenging phosphate in environments where this is a limiting factor, thus inhibiting growth 
of diatoms [29]. This is further complicated by environmental factors that lead to beneficial 
interactions turning sour when e.g. nitrate is scarce while dissolved organic carbon is high [30].  
 
When conditions are favorable, biofilms are present in virtually all environments [31]. Due to 
the opportunistic and persistent nature of biofilms, treatment is notoriously troublesome, 
causing harmful and chronic infections. Thus, finding new anti-biofilm agents is of great 
interest. Microbial biofilms in the marine realm usually consist of bacteria and benthic diatoms, 
e.g. species of Navicula, Cylindrotheca and Nitzschia, and a number of studies have therefore 
been conducted to find ways to combat diatom biofilm formation [32, 33]. In comparison, very 
little has been done to map the diatoms' own ability to fight bacterial biofilm. Previous 
bioactivity studies of the temperate marine diatom Porosira glacialis have revealed that the 
species harbor anti-biofilm activity against S. epidermidis [34, 35].  S. epidermidis is a common 
member of the human epithelial microflora skin and is usually harmless to humans, but it is 
also an important opportunistic pathogen [15]. Together with S. aureus it causes 2/3 of 
nosocomial infections in patients. Staphylococcus epidermidis is often used as test organism in 
anti-biofilm assays, as it easily forms biofilm and is a good indicator for possible anti-biofilm 
activity. The need for new treatments of bacterial biofilm combined with results from previous 
studies have motivated a further investigation of the anti-biofilm activity of P. glacialis. The 
purpose of the study was to investigate the anti-biofilm activity in organic extracts from the 
marine diatom Porosira glacialis using bioassay guided isolation with the aim of isolating and 
identifying the active compounds. 
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Materials and Methods  
Mass cultivated diatoms  
Cultivation was performed similar to [36], with some modifications. Mono algal - non-axenic 
mass culture of the cold-water diatom species Porosira glacialis was mass cultivated outdoors 
in a roofed and open 300 000 L fibreglass cylindrical open airlift photobioreactor. The 
cultivation took place during December 2019 at 5.1 – 5.9°C using solely artificial light 
provided by LED lamps. The diatoms were cultivated under a mean scalar irradiance of 36-50 
μmol photons m−2 s−1 as measured at 0.7 m depth with a Li – 1500 light logger using a Li – 
193SA spherical underwater quantum sensor (Li-Cor Biosciences, USA). The culture was 
maintained in exponential growth phase with cell numbers at 8-9 million cells L -1. Nitrate was 
kept between 90-100 μM (Spectroquantâ “Silicate (Silicic Acid) Test”, Merk, Damstadt, 
Germany), while silicate varied from 18-59 μM (Spectroquantâ “Nitrate test in seawater”, 
Merk, Damstadt, Germany). Harvested biomass was centrifuged using a continuous centrifuge 
(Evodos 10, Evodos B.V., The Netherlands) and stored at -80°C.  
 
Material preparation and separation 
Extraction  
Harvested biomass of P. glacialis was freeze-dried (Heto PowerDry PL9000, Thermo Fisher 
Scientific, Waltham, MA, USA) and ground into a fine powder. The dried biomass was 
extracted using MilliQ-H2O overnight at 5°C, then centrifuged at 4600 rpm at 4°C for 30min. 
The pellet was resuspended in MilliQ-H2O for 1h and centrifuged. The extracted pellet was 
freeze-dried and extracted for 4h with a 1:1 mixture of dichloromethane (Merck, Darmstadt, 
Germany) and methanol (MeOH, Merck) before being filtrated through a Whatman Ø 152 mm 
no. 3 filter. The organic extraction was repeated twice. The supernatant was dried in a rotavapor 
under reduced pressure and stored at -23°C until further use.  
 
Flash fractionation  
The extract was fractionated using a Biotage HPLC SP4 flash fractionation system (Biotage, 
Uppsala, Sweden). A subsample (1.5 g) of the organic extract was dissolved in 40 mL g-1 of 
hexane (Merck) and transferred to a separation funnel. A liquid:liquid partitioning was 
performed by adding 2x30 mL 90% MeOH (Merck). The lower phase (MeOH) was retrieved 
and mixed with 2 g of Dianon HP-20SS resin (Supelco, Bellefonte, PA, USA) and subsequently 
dried under reduced pressure. The columns were prepared by mixing 6.5 g of resin with MeOH 
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for 20 min, then washing with MilliQ-H2O and transferring the material to a flash column 
(Biotage SNAP, Uppsala, Sweden). The column was equilibrated with 5% MeOH and the 
extract was loaded onto the column. Fractionation was done using two consecutive methods. 
First: a 5-100% MeOH gradient over 32 min with, second a MeOH:Acetone (Merck) gradient 
ending at 100% acetone over 18 min. Eight fractions were collected and dried under reduced 
pressure. The fractions were dissolved in 100 % DMSO (Merck) and stored at -20 °C until use. 
Plates with the desired concentration of fractions were prepared prior to bioactivity testing and 
diluted in dH2O.  
 
HPLC fractionation  
Flash fractions with detected activity were re-fractionated into new 40 fractions using a 
preparative high-pressure liquid chromatography (prep-HPLC) system. The prep-HPLC 
consisted of a 600 HPLC pump, a 2996 photodiode array UV-detector, a 3100 - mass 
spectrometer, and a 2767 sample manager (Waters, Milford, MA, USA). The solvents used 
were A: MilliQ-H2O + 0.1 % formic acid (FA) and B: Acetonitrile (ACN) + 0.1 % FA. Gradient 
30-70% ACN over 40 min (1 fraction min-1), flow 6 mL min-1. Samples were injected into a 
Xterra Prep MS C8 (10 µm, 10x250mm) column (Waters). Fractions were transferred to 96 
well, deep well plates, freeze dried and stored at -20°C until further use. HPLC fractions were 
dissolved in DMSO (Merck) and diluted with dH2O before bioactivity testing.  
 
Bioactivity testing  
Biofilm assay – inhibition of biofilm formation  
The biofilm inhibition assay used S. epidermidis and was performed following Lauritano et al. 
(2016). In brief, triplicates of FLASH fractions from extracted diatom biomass were used to 
test biofilm formation the bacteria Staphylococcus epidermidis (ATCC – 35984). We added 50 
μL fraction and 50 μL bacteria suspension to each well in microtiter plates (96-wells), using 
MilliQ water and enriched media (1:1) as blank, Staphylococcus haemolyticus as negative 
control, while S. epidermidis with MilliQ water was the positive control. Visual inspection of 
biofilm formation in the plates was backed by measuring absorbance at 450 nm using a 





Biofilm assay – eradication of established biofilm  
The biofilm eradication assay was performed using S. epidermidis incubated overnight at 37°C 
and then diluted 1:100 in tryptic soy broth (TBS) with 1% glucose added.  50 µL Bacterial 
culture and 50 µl dH2O was then transferred to each well in a 96 well plate (Nunc). Blank 
consisted of TBS with 1% glucose mixed 1:1 with dH2O, S. haemolyticus was used as negative 
control, while positive control was S. epidermidis. The resulting plates were incubated for 24h 
at 37°C, then emptied and washed twice with phosphate-buffered saline (PBS). New TBS with 
1% glucose was then added in addition to fractions (50 µL) in triplicates and incubated again 
for 24h at 37°C. Plates were then fixed, colored and measured following the same methodology 
as in the inhibition of biofilm formation assay [38].  
 
Growth inhibition assay  
Antibacterial testing was done following Ingebrigtsen et al (2016) [39]. In brief, we used the 
following strains (American Type Culture Collection Strain (ATCC) numbers in parentheses): 
Enterococcus faecalis (29212), Staphylococcus aureus (25923), Streptococcus agalactiae 
(Streptococcus Gr. B, ATCC 12386), Escherichia coli (25922) and Pseudomonas aeruginosa 
(27853). E. faecalis and S. agalactiae were enriched with Brain Heart Infusion (BHI, Sigma-
Aldrich) and the other strains with Mueller – Hinton broth (MH, Becton Dickinson, Franklin, 
NJ, USA). Log phase cultures were diluted 1:1000 with their respective enrichment medium 
before being transferred (50 µL) to clear 96-well plates. Flash fractions were tested at a 
concentration of 50 µg/mL. Absorption at 450 nm values were measured using a 1420 
Multilabel Counter VICTOR3, values below 0.05 were regarded as “active”. To allow for post 
– compensation, the plates were visually checked and measured prior to addition of bacteria as 
well. Blanks were 50 µL sterile water with 50 µL enrichment media, growth controls were 50 
µL bacterial solution and 50 µL sterile water while Gentamicin (Aventis Pharma) was used as 
positive control. 
 
Toxicity assay HepG2  
Active HPLC fractions were screened for cytotoxicity using human hepatocellular carcinoma 
cell line HepG2 (ATCC HB-8065) and normal lung fibroblasts MRC5 (ATCC CCL-171). The 
HepG2 cells were suspended in MEM Earle’s cell medium (Biochrom GmbH, Berlin, 
Germany) and MRC5 in Roswell Park Memorial Institute 1640 (RPMI, Sigma-Aldrich), both 
with 10% foetal bovine serum. 4000 (MRC5) and 2000 (HepG2) cells were seeded into the 
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wells of a 96-Well Nunc plate (Nunc, Roskilde, Denmark) and incubated at 37 °C in 5% CO2 
for 24h. The culture medium was then replaced with new VEKST with 10% FBS and 
gentamycin (10 µg mL-1), the fractions or isolated compounds were added (25 and 50 µg mL-
1) and the plate was incubated for 72h at 37°C in 5% CO2. All samples were tested in triplicates, 
negative control was growth medium and positive control was growth medium with 10% 
DMSO. After incubation, 10 µL CellTiter 96® AQueous One Solution Reagent (G3581, 
Promega, Madison, WI, USA) was added to each well and incubated for 1h. The plates were 
read using a DTX 880 plate reader (Beckman Coulter, CA, USA) at 495 nm.  
 
Purification  
The initial purification of compounds was performed using the same prep HPLC-MS system 
used for fractionation, using the same column (Xtrerra). The fraction collector was triggered 
by m/z of the selected compound, or by time (retention time) if trigger by m/z was not possible. 
Several gradients of A: MilliQ-H2O + 0.1 % FA and B: Acetonitrile (ACN) + 0.1 % FA were 
used in the purification process to favour best possible separation and isolation of selected 
compounds. The second purification step was performed using a semi-preparative HPLC 
system coupled to a PDA and QDa-MS. The HPLC system was equipped with a Sample-
manager FTN-R, Quaternary-solvent-manager (HPLC-pump), isocratic solvent manager, 
column-oven, QDa detector, a 2998 PDA detector and a fraction manager, all ACQUITY-
ArcTM components, (Waters). For separation a AtlantisTM T3 3 µm, 3.0×150 mm C18 column 
(Waters) was used. Solvents used were, A: ddH2O + 0.1% FA and B: ACN + 0.1% FA. 
Gradients were adapted to achieve best possible separation and isolation of selected 
compounds.  
 
HR-MS analysis  
Active fractions and isolated compounds were analyzed using UHPLC-HR-MS for 
dereplication. The system used was a Acquity I-class UPLC (Waters, Milford, MA, USA) 
coupled to a PDA detector and a Vion IMS QToF (Waters). The chromatographic separation 
was performed using an Acquity C-18 UPLC column (1.7 m, 2.1 mm_100 mm) (Waters). 
Mobile phases consisted of A: ddH2O (Millipore, Burlington, MA, USA) + 1% FA and B: 
CAN (HiPerSolv, VWR, Radnor, PA, USA) + 1% FA. The gradient was run from 10% to 90% 
B in 12 min at a flow rate of 0.45 mL/min. Samples were run in ESI+ and ESI- ionization 




NMR spectra were acquired in d6-DMSO on a Bruker Avance III HD spectrometer operating 
at 600 MHz for protons, equipped with an inverse TCI cryo probe enhanced for 1H, 13C and 
2H. 1H/13C chemical shifts were referenced to the residual solvent peak (d1-DMSO: dH = 2.50 
ppm, 13C d = 39.52 ppm). 
 
Results  
Large-scale cultivation  
The cultivation of P. glacialis used in the present study was cultivated in large-scale in a 
300,000 L fibreglass cylindrical open airlift photobioreactor. A visual control of the cells was 
performed daily using an inverted microscope to ensure that the culture remained healthy and 
that there was no contamination of other species of microalgae. The monoculture of P. glacialis 
remained healthy throughout the cultivation period. The harvest was performed using a semi-
continuous centrifuge, removing app. 99 % of the water content resulting in 500 g wet weight 
of diatom biomass. Freeze drying and extraction yielded 41 g aqueous extract and 8,9 g organic 
extracts for flash fractionation and further isolation. Aqueous extract was not subject to in depth 
analysis in the present study, due to lack of bioactivity. 
 
Bioactivity guided isolation  
The organic extract of P. glacialis was fractionated into 8 fractions, which were all tested in an 
anti-biofilm assay for inhibition of biofilm formation by S. epidermidis at 50, 25, 20 and 5 µg 
mL-1. All fractions were tested in 3 technical replicates. Out of the eight organic flash fractions 
tested, two fractions showed activity in a dose-response manner (Figure 1). Both fractions (F3 
and F4) showed activity at 25 µg mL-1 as the fractions were regarded as active < 25% biofilm 
coverage.  
 
Based on the activity, F3 and F4 were further fractionated using prep-HPLC into 40 fractions 
each. The HPLC fractions were tested in two anti-biofilm assays, both for inhibition of biofilm 
formation and eradication of established biofilm. Out of 80 tested fractions, 6 fractions showed 
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ability to inhibit biofilm formation (Figure 2), while 3 fractions removed established biofilm 
formed by S. epidermidis (Figure 3).  
Figure 1: Dose-response assay on inhibition of biofilm formation by organic Flash fractions F3 and F4 from 
P. glacialis.  Fractions were tested at concentrations: 50, 25, 10 and 1 µg mL-1. Inhibition was measured in 












































































































































































































































































































Figure 3: Inhibition of biofilm formation by re-fractionated active fraction F3 (a) and F4 (b) from organic extracts of P. 
glacialis. HPLC-Fractions were regarded as active below 25% biofilm coverage. 
 
Figure 2: Inhibition of biofilm formation by re-fractionated active fraction F3 (a) and F4 (b) from organic extracts of P. 




The HPLC fractions were also tested in an anti-bacterial growth inhibition against 5 bacterial 
strains: Enterococcus faecalis, Staphylococcus aureus, Streptococcus agalactiae 
(Streptococcus Gr. B), Escherichia coli and Pseudomonas aeruginosa. The results are 
presented in Figure 4, showing that 4 HPLC fractions inhibited growth of S. aureus, while 6 
fractions inhibited the growth of E. faecalis. The active fractions and the surrounding, non-
active fractions were tested for cytotoxicity against human hepatocellular carcinoma cell line 










Figure 4: Activity profiles of HPLC fractions (re-fractionation of active fraction F3 and F4) of P. glacialis tested 
in a growth inhibition assay against S. aureus (a and b) and E. faecalis (c and d). Fractions were regarded as active 
at abs. <0.05 at 450nm. 
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Isolation and structure elucidation  
The active and inactive HPLC fractions were analysed using HR-MS to find compounds that 
were unique for the active fractions, and these were purified using preparative HPLC. This 
resulted in six target compounds which were attempted isolated. The collected six fractions 
were dried under reduced pressure to about 10 % of collected volume and redissolved in 
MeOH. To remove impurities from the target compounds, they were purified a second time 
using a different prep-HPLC system. The second purification resulted in three compounds 
(mbc-346, mbc-347 and mbc-348) that were evaluated to be pure enough for structure 
elucidation using NMR. The remaining three compounds (mbc-343, 344 and 345) were 
included in the bioactivity testing. All compounds were freeze-dried. Structure elucidation by 
NRM resulted in the structures of mbc-346 and mbc-347 that could be determined based on 
the available NMR and MS data. Table 1 shows the freeze-dried yield of all six compounds 
isolated and tested. 
 
Table 1: Compound yield of all 6 compounds isolated from P. glacialis 
Compound ID Weight (mg) NMR structure 
Mbc-343 0,2 No 
Mbc-344 0,9 No 
Mbc-345 1,5 No 
Mbc-346 3,7 Yes 
Mbc-347 0,1 Yes 
Mbc-348 1,5 No 
 
 
Compound mbc-346 was isolated as a light-yellow wax. Through 1D (1H and 13C, table 2, 
Figure S1 and S2) and 2D (HSQC, HMBC and COSY, Figure 5, S3 and S4) NMR experiments, 
mbc-346 was determined to be the previously known compound methyl 3-
hydroxyoctadecanoate (Figure 5).  Through HMBC and COSY, two subfractions of the 
molecule were unambiguously assigned (positions 1 – 7 and 17 – 19 in Figure 5). Signals for 
both hydrogen and carbon atoms 8 to 16 (all CH2 and part of the aliphatic chain) overlapped 
and could not be distinguished from each other.   
 
NMR data obtained for mbc-347 clearly indicates that this compound is or is closely related to 
pheophorbide A. However, only subfractions of the chlorophyll breakdown product could be 
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determined. Due to low sample amounts, only five clear peaks were visible in the carbon 
spectrum. Pheophorbide A and related compounds have a ratio of carbon to proton atoms of 
around 1:1, which complicated the structural elucidation proses. Furthermore, the sample was 
found to change over the course of the NMR experiments. The substructures that could be 
determined for mbc-347 using NMR data are highlighted in Figure 6.  
 
Table 2: 1H and 13C NMR Assignments for mbc-346 
 δC, type δH, type (J in Hz) 
1 51.1, CH3 3.57, s 
2 171.8, C  
3a 42.4, CH2 2.39, dd (14.7, 4.7) 3b 2.28, dd (14.7, 8.3) 
4 67.1, CH 3.80, m 
5 36.9, CH2 1.39 - 1.30, m* 
6a 25.0, CH2 1.39 - 1.30, m* 6b 1.24, m* 
7 28.7, CH2 1.28 - 1.18, m* 
8 29.1 - 29.0, CH2* 1.28 - 1.18, m* 
9 29.1 - 29.0, CH2* 1.28 - 1.18, m* 
10 29.1 - 29.0, CH2* 1.28 - 1.18, m* 
11 29.1 - 29.0, CH2* 1.28 - 1.18, m* 
12 29.1 - 29.0, CH2* 1.28 - 1.18, m* 
13 29.1 - 29.0, CH2* 1.28 - 1.18, m* 
14 29.1 - 29.0, CH2* 1.28 - 1.18, m* 
15 29.1 - 29.0, CH2* 1.28 - 1.18, m* 
16 29.1 - 29.0, CH2* 1.28 - 1.18, m* 
17 31.3, CH2 1.23, m* 
18 22.1, CH2 1.25, m* 
19 14.0, CH3 0.85, t (6.9) 










Anti-biofilm activity of isolated compounds   
All six isolated compounds were tested for anti-biofilm activity at two different concentrations 
50 and 25 µg mL-1 (Figure 7). At 50 µg mL-1 activity was found for compound mbc-346, 
identified to be methyl 3-hydroxyoctadecanoate. Results showed that after 24h, there was 57 
% biofilm coverage, compared to 120 % by non-active compounds. Compound mbc-347, 
pheophorbide a, showed some inhibition with 68 % coverage at 50 µg mL-1. The compounds 
that could not be analysed by NMR were also tested, and compound mbc-348 (isolated by mass 
m/z 641) showed activity at both 25 and 50 µg mL-1 with 40 and 44 % coverage respectively. 
All compounds were also tested for eradication of established biofilm at 50 µg mL-1, though 
no activity was found in this assay. A bacterial growth inhibition assay was performed, 
revealing no activity at 25 µg mL-1. A viability assay towards normal lung fibroblasts (MRC5), 
revealed no cytotoxicity at 25 µg mL-1 for any of the tested compounds.  
 
Figure 6: The structure of pheophorbide A. The 
subfractions that could be determined following 





Bioassay guided isolation was used to identify compounds in the marine diatom Porosira 
glacialis with anti-biofilm activity towards Staphylococcus epidermidis. Continuous 
cultivation of P. glacialis in large scale over a period of > 4 months has showed very little 
visible formation of biofilm inside the photobioreactor, as well as on submerged equipment. 
This, in addition to previously found anti-biofilm activity in extracts of P. glacialis motivated 
an isolation of compounds with possible anti-biofilm activity [34, 35]. S. epidermidis was used 
as the test bacteria due its qualities as a biofilm forming bacteria, and as a good indication of 
anti-biofilm activity. Anti-biofilm activity was found in two organic Flash-fractions (F3 and 
F4) from the organic extract of the cultivated diatoms. In order to isolate individual compounds 
responsible for the observed bioactivity, the Flash fractions which were further fractionated 
using preparative HPLC into 40 fractions each. The bioactivity was recovered in six of these 
HPLC fraction, allowing us to compare active and inactive fractions to identify potential 
bioactive compounds, finally resulting in six compounds isolated.  
 
Compound mbc-346 inhibited formation of biofilm by S. epidermidis at 50 µg mL-1 (57 % 
coverage, see Figure 7). The compound was confirmed to be methyl 3-hydroxyoctadecanoate 
by NMR analysis. Methyl 3-hydroxyoctadecanoate is a known hydroxy fatty acid methyl ester 









MBC-343 MBC-344 MBC-345 MBC-346 MBC-347 MBC-348
50  µg/mL 25 µg/mL
Figure 7: Bioactivity testing of isolated compounds for Inhibition of biofilm formation. Biofilm 
measured in % biofilm coverage. Compounds tested at 50 and 25 µg mL-1. 
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Acokanthera schimperi [40, 41] and from the bacteria Thiobacillus thioxidans [42]. There are 
no previous reports on the compound being isolated from diatoms, or microalgae in general. 
Another hydroxy fatty acid methyl ester, Urs-12-en-28-oic acid, 3-hydroxy-, methyl ester, (3β) 
isolated from the plant Barleira courtallica have shown antimicrobial, anti-inflammatory and 
cytotoxic activity [43]. Apart from this there are little reports connecting hydroxy fatty acid 
methyl esters to bioactivity, and none to anti-biofilm activity, but there are previous studies 
reporting antibacterial activity in free fatty acids isolated from diatoms, e.g. eicosapentaenoic 
acid (EPA) [44]. This could suggest that the anti-biofilm activity could possibly be linked to 
fatty acids in P. glacialis.  
 
Compound mbc-347 identified was as a pheophorbide-like compound and showed some degree 
of inhibition of biofilm formation at 50 µg mL-1 compared to the non-active compounds (68 % 
biofilm coverage). Pheophorbide a has previously shown anti-inflammatory [45] activity and 
anti-viral activity (hepatitis C virus) [46]. Pheophorbide-like compounds have also showed 
some cytotoxic effect [47]. Compound mbc-348 showed activity at both 25 and 50 µg mL-1, 
although the biofilm coverage was 40 % at each concentration showing that the activity was 
not dose-dependent. Compound mbc-348 was not of high enough purity for NMR, thus a 
structural elucidation is not available. Data form the UPLC-HR-MS analysis of this compound 
were very hard to interpret and we were unable to calculate a reliable elemental composition, 
but the mass used as fraction trigger for this compound (m/z 641) on the preparative HPLC, 
suggested that it could also be a chlorophyll derivate.  
 
The bioactivity testing of HPLC fractions revealed fractions which removed established 
biofilm as well as having antibacterial activity towards Staphylococcus aureus and 
Enterococcus faecalis. These activities were not detected in the isolated compounds, 
suggesting that either the test concentration (50 µg mL-1) was too low or that the activity was 
caused by synergies between several compounds. Another option is certainly that there could 
be more bioactive compounds yet to be isolated form the P. glacialis extract.  
Conclusion 
The absence of biofilms in large scale cultures of P. glacialis is a valuable asset, and in this 
study, we have been able to at least partially ascribe this activity to two isolated and 
characterized compounds; methyl 3-hydroxyoctadecanoate (mbc-346) and a pheophorbide-like 
structure (mbc-347). The bioactivity of compound mbc-346 is interesting as it is the first report 
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on the isolation of this compound from a diatom. It is also the first evidence of anti-biofilm 
activity of this group of compounds. Further investigation of the anti-bacterial and anti-biofilm 
activity of fatty acids from P. glacialis could be of interest. Such activity, if shown to be the 
result of degradation of primary metabolites present in most, if not all, microalgae species used 
in microalgae mass cultivation, would aid in explaining the low level of biofilm in bioreactor 
systems using similar cultivation conditions. In turn, this could inspire efforts to optimize 
towards cultivation conditions where the microalgae produce higher levels of the compounds 
leading to less biofilm formation, thus saving money on costly cleaning. Furthermore, the 
isolated compound, methyl 3-hydroxyoctadecanoate, could be of commercial interest in itself 
as a possible detergent or treatment of biofilm, biologically produced from a renewable and 
sustainable source.  
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Figure S1. 1H NMR spectrum of mbc-346 
 
 
Figure S2. 13C NMR spectrum of mbc-346 
 
Figure S3. HSQC + HMBC spectrum of mbc-346 
 
Figure S4. COSY spectrum of mbc-346 
 
 
 
 
 
